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Globally, the number of overweight and obese adults has risen dramatically in the last 
three decades(1). This rise is accompanied by a rapid increase in childhood overweight 
and obesity, with prevalence rising in this period in both developed and developing 
countries(2,3). In clinical practice, subjects are usually defined according to body 
mass index (BMI). BMI is calculated by dividing the weight of a subject by its length 
in meters squared. Adults are considered overweight when BMI exceeds 25 kg/m2 and 
are classified as severely overweight or obese when BMI is over 30 kg/m2. For children, 
age and sex specific standard deviation curves are available, corresponding with the 
25 and 30 kg/m2 limits used in adults(4), which adjust for differences in body composi-
tion for children and adolescents at different ages. In the Netherlands, in 2016, 50,2% 
of adults (>20 years of age) were overweight of which 14,5% were obese(5). The most 
recent national growth study, performed in 2009, showed that approximately 14% of 
children in the Netherlands are classified as overweight and 2% of children are classified 
as obese(6). In both adults and children, these increases cause a rise in overweight and 
obesity associated diseases such as type 2 diabetes, metabolic syndrome, hepatic ste-
atosis or psychological diseases, like depression(7-12). In turn, this leads to major rises in 
healthcare expenses. Globally, the annual costs of obesity are estimated to be 2 trillion 
US dollars(13). Therefore, reducing obesity prevalence and timely diagnosing obesity as-
sociated diseases are of the utmost importance. Recent meta-analysis on the success of 
treatment programs for obesity, however, show that the effect of lifestyle interventions 
are still limited(14, 15). This lack of success has been posed to result from an insufficient 
understanding of the complex endocrine, genetic, metabolic, neurological, psychologi-
cal and societal factors known to be associated with obesity. Extending the knowledge 
on how these factors influence feeding behaviour and metabolism is crucial for further 
development of therapy. The second part of this thesis will be dedicated in investigating 
the associations of brain structure and function with obesity, feeding behaviour and 
genetics.  
In recent years, an additional topic of debate, specifically in children, is the extensive-
ness of the diagnostic work-up of overweight and obese children. On the one hand, 
when and how to screen for underlying pathology such as hormonal, syndromic or 
monogenic diseases is an important task of clinicians.  Assessment of growth, pubertal 
development and bone age are the cornerstone of this diagnostic workup. However, 
accelerated growth, puberty and bone age can be caused by obesity itself and can be 
difficult to discriminate from illnesses. On the other hand, clinicians are faced with the 
question when and how to screen for co-morbidities in overweight and obese children. 
The discussion is focussed on finding paediatric patients at high risk of developing co-
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morbidity. The third part of this thesis will focus on tests that are used in the diagnostic 
work-up in overweight and obese children.  
neurological basis of feeding behaviour
In recent years, scientists have increasingly focussed on the role that the brain plays in 
feeding behaviour as a model for understanding obesity. From a perspective of feed-
ing being needed to maintain energy balance, we now know that the hypothalamus 
and brainstem are key areas involved in maintaining this balance(16,17). These areas 
receive hormonal and neural input on energy balance from the digestive system (e.g. 
ghrelin, leptin and vagal nerve), endocrine organs such as the pancreas (e.g. insulin) and 
adipose tissue (i.e. leptin), and forward information to various cortical and subcortical 
brain structures, thereby signalling when energy is needed to maintain energy storage 
by inducing a feeling of hunger, and signalling when enough energy is taken in to 
maintain balance by inducing a feeling of satiety(17-19). Feeding behaviour, however, 
is not only driven by energetic demands, but also by the rewarding properties of foods. 
Seeing, smelling, or even thinking about food can trigger brain areas involved in reward 
and salience processing, resulting in an intensive drive to eat, even when there is no 
energetic demand. This is the result of activity in a complex of brain structures that ulti-
mately makes us experience pleasure when we eat something palatable and, in sudden 
situations, make us feel hungry when we are, energetically speaking, satiated(20-25). 
Central in reward processing, is dopamine release by neurons originating from the 
ventral tegmental area into subcortical and cortical brain structures, such as the nucleus 
accumbens, amygdala and medial prefrontal cortex(16). These neurons release dopa-
mine when a person anticipates on receiving a rewarding stimulus, such as food. This 
anticipatory state can, in the case of food, be triggered by stimuli, such as seeing or 
smelling palatable foods, and leads to food seeking behaviour. When said food is taken 
in this again leads to dopamine release. Under normal conditions, these reactions are 
more pronounced in a hungry, than in a satiated state(21,22) and are under the influ-
ence of hormonal feedback from the digestive system through direct as well as indirect 
signalling via the hypothalamus (16,18,19,26). In addition, various cortical structures, 
mainly in the frontal lobe, are involved in exerting control over food intake, by interact-
ing with the dopaminergic reward system and thereby controlling food intake(19,27-31). 
Furthermore, the visual cortex plays an important role in this system, since it is involved 
in signalling stimuli and, in collaboration with frontal areas, determines whether it 
draws the attention of an individual(32). In recent years, these brain systems have been 
increasingly investigated to find if they differ in persons with obesity. 
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Behavioural and neural aspects of obesity
Neuropsychological data have shown that people with obesity differ from their peers 
in a variety of traits. For instance, subjects with obesity show a reduced responsiveness 
to satiety signalling, an increased responsiveness to the rewarding value of food and 
perform poorer on tests of executive function (i.e. a collective term for self-regulatory 
processes such as inhibition, working memory and attention), possibly reflecting a lack 
of control over feeding behaviour(30,33,34). This, combined with the rise of MRI as a 
modality to very precisely investigate both structure and function of the brain, led to an 
increase of imaging studies on the brains of obese subjects. 
It was shown that people with obesity, children as well as adults, differ in volume and 
cortical thickness in areas known to be involved in reward and salience processing as well 
as executive function(30, 35-39). With the rise of functional magnetic resonance imaging 
(fMRI), which measures the blood oxygen level dependent (BOLD) signal, a derivative of 
brain activity, it was shown that people with obesity differ in activation, after seeing, 
smelling or tasting food cues, in areas implicated in reward and salience processing (e.g. 
nucleus accumbens, medial prefrontal cortex and amygdala), hunger and satiety signal-
ling (e.g. the hypothalamus) and areas implicated in exerting control over behaviour 
(e.g. the dorsolateral prefrontal cortex and anterior cingulate cortex)(27-29, 40-43). 
Little is known, however, on said structural and functional differences in the brain, and 
how these relate to other factors related to obesity, such as behaviour and genetics. 
Furthermore, fMRI research recently evolved from investigating activation, to research 
on between structure communications, by means of connectivity analysis(44-48). This 
allows for the connectivity of networks of brain structures to be evaluated, as a proxy 
of communication. Although some knowledge has been assembled using connectiv-
ity analysis in obese adults, very little is known on connectivity differences in younger 
subjects with obesity. Therefore, part II of this thesis aims to investigate:
• Whether (variations in) brain volume and thickness correlate with executive function, 
appetitive and reward related behaviours and genetics in obese and lean subjects. 
• Whether adolescents with and without obesity differ in resting state brain connectiv-
ity, with a specific focus on areas involved in hunger and satiety signalling, executive 
function and reward and salience processing.
Diagnostic work-up of overweight paediatric patients in clinical practice  
The diagnostic work-up of overweight paediatric patients has been the subject of debate 
for years. The main goal of the diagnostic work-up is early identification of co-morbidity, 
such as impaired glucose tolerance, type 2 diabetes, hypertension and dyslipidemia 
and identification of underlying pathology. As underlying causes and co-morbidity of 
obesity, are relatively rare at young age, discussions on cost effectiveness of extensive 
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diagnostic protocols are ongoing. Therefore, further research in identification of patients 
at high risk for co-morbidity and underlying causes of obesity is warranted. 
Diagnosing underlying pathology causing obesity has proven challenging. Assess-
ment of growth, puberty and bone age are the cornerstone of the diagnostic work-up 
to find endocrine, syndromic or genetic causes of obesity. Children that are obese 
without underlying pathology, however, also show alterations in growth, puberty and 
bone age. On average, they show accelerated growth in height, earlier timing of puberty 
and advanced bone age(49-55). In this, they differ from endocrine causes of obesity, 
such as Cushing’s disease and hypothyroidism, which usually show blunted growth in 
height(56,57). In contrast, it is much harder to use these parameters to differentiate life-
style obesity from obesity caused by monogenic (e.g. MC4R mutations) and syndromic 
(e.g. overgrowth syndromes) causes of obesity, since they can also show accelerated 
height growth and bone age advancement(58). The problem of differentiating lifestyle 
obesity from other underlying causes of obesity with accelerated maturation might 
stem from the lack of understanding of the pathophysiological mechanism driving bone 
age advancement and accelerated growth. Therefore, unravelling these mechanisms is 
highly beneficial in the clinical practice. 
Already in childhood, some children with obesity are affected by diseases caused by 
excess weight, such as glucose derailment (e.g. type 2 diabetes), hypertension, dys-
lipidaemia and fatty liver disease(7,10-12,59). Although incidences of diseases such as 
type 2 diabetes and hypertension are low and symptoms are mild compared to adults, 
they indicate an increased risk of developing serious co-morbidity in adulthood(10,60). 
For instance, presence of prediabetes (i.e. a relatively mild rise in glucose levels) at 
young age, was shown to be associated with a high chance of developing diabetes in 
early adulthood, especially when BMI increased(60).  The combination of relatively low 
incidence of co-morbidity in overweight paediatric patients, combined with the high 
volume of young overweight subjects and severe consequences of co-morbidity at 
young age for adult life pose the challenge of finding a diagnostic strategy that is highly 
sensitive and specific, thereby being cost-effective. 
Given the challenges in clinical practice considering the diagnostic workup over over-
weight and obese paediatric patients, the aims of part III of this thesis are:
•	 To	investigate	what	drives	accelerated	growth	and	concomitant	bone	age	advance-
ment in childhood obesity. 
•		 To	investigate	which	parameters,	available	in	everyday	practice,	predict	the	presence	
of impaired glucose tolerance in overweight and obese paediatric patients.
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OutLInE Of thE thEsIs
Part I General introduction
Chapter 1 gives a brief overview of the topics investigated in this thesis.
Part II Behavioural, genetic and neural aspects of obesity
Chapter 2 describes the relationship between brain structure, appetitive traits and 
executive function in lean and obese adolescents.
Chapter 3 reports on differences in resting state activity between lean and obese ado-
lescents.
Chapter 4 descibes the investigation of the relationship of the FTO risk-allele, rs9939609A, 
and volumes of reward related brain structures is reported.
Part III Diagnostic workup of overweight paediatric patients in clinical practice  
Chapter 5 describes the relationship of various endocrine parameters with advanced 
bone age in obese children and adolescents. 
Chapter 6 reports on markers for improving predictability of impaired glucose tolerance 
in overweight and obese children and adolescents.
Part IV General discussion and summary
Chapter 7 gives a general discussion on the results of the studies included in this thesis 
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Children with obesity show differences in brain structure, executive function and appeti-
tive traits when compared to lean peers. Results of imaging studies, however, have been 
contradictory. Therefore, we investigate whether childhood obesity is associated with 
differences in brain structure and whether differences associate with executive function 
and appetitive traits.
Methods 
A cross-sectional case-control study among 23 obese and 19 lean control subjects, 
aged 12-16 years, was conducted. Brain structures were measured by MRI using Voxel 
Based Morphometry, cortical thickness and subcortical volumes.  Appetitive traits were 
measured by the Child Eating Behaviour Questionnaire and executive function by a Stop 
Signal Task and a Choice Delay Task. Associations between brain structures and appeti-
tive traits or executive function tests were investigated using linear regression analysis. 
results 
Obese adolescents had larger volumes of the pallidum; 1.78 mL (SE 0.03, p=0.014), 
when compared to controls; 1.65 mL (SE 0.02). In the obese group, increased pallidal 
volume was positively associated with the ability to delay reward in the Choice Delay 
Task (p=0.012).
Conclusion 
The positive association of pallidal volumes and Choice Delay Task found in obese ado-
lescents supports the hypothesis that the pallidum plays an important role in executive 
dysfunction described in obese children.
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IntrODuCtIOn
A global rise in childhood obesity was seen in the last decades(1), leading to adverse 
outcomes, such as type II diabetes and metabolic syndrome(2). Early intervention in 
children is key to prevent adult disease. Obesity treatment, however, often fails because 
complex mechanisms in satiety, craving and reward systems play a role. Unravelling 
these mechanisms is currently the subject of research. 
Neuroimaging studies investigating brain structure in childhood obesity suggest that 
overweight and obese children and adolescents differ from lean peers in subcortical 
reward related regions. Reduced(3), as well as increased(4) hippocampal volumes, 
increased size of the pallidum(3), and reduced volume of thalamus(5) have been 
described. Furthermore, in literature on obesity in adults, increased volume of the 
amygdala(6), thalamus(7), caudate nucleus(7), reduced volume of the putamen(8) and 
increased(6) as well as reduced(9) hippocampal volumes have been described in rela-
tion with a higher BMI. Additionally, in childhood obesity, as well as in literature on adult 
obesity, reductions in volume and cortical thickness, in regions involved in executive 
function (a collective name for self-regulatory processes) and reward processing, have 
been reported(4, 7, 9-11). Recent research suggests that reductions in brain volume and 
cortical thickness found in obese children might be caused by presence and duration of 
the metabolic syndrome(11). 
Previous research on the behaviour of children with obesity has shown that they ex-
hibit differences in executive function when compared to lean peers. More specifically, 
children that are overweight or obese are posed to have deficits in inhibitory capacity, 
possibly indicating they have problems to refrain from eating(12). Furthermore, they 
are reported to have problems delaying gratification(12). In other words, they tend to 
choose small, immediate rewards, such as high-calorie foods, over larger delayed re-
wards, such as a healthier weight. Moreover, childhood obesity is frequently associated 
with differences in appetitive traits when compared to lean peers(13). Research in this 
field shows that children with obesity are less sensitive to satiety signals, have increased 
responsiveness to food cues and find food more rewarding than lean peers(13). However, 
knowledge on structural neurological correlates possibly underlying this behaviour, is 
limited. 
Although some neuroimaging studies have included a measure of executive function 
in their design, very few studies have specifically investigated inhibitory control, and 
none have specifically investigated delay of gratification. One study found that volumes 
of the dorsolateral prefrontal cortex were negatively correlated with inhibition measured 
by a Stroop task in lean but not in obese children(4). Another study found that reduced 
grey matter volume in the orbitofrontal cortex correlated with increased disinhibition in 
lean, but not obese children, as measured by an eating questionnaire(10). Moreover, to 
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our knowledge, the relationship between appetitive traits and brain structure has never 
been investigated in obese children. 
In conclusion, there is limited knowledge on brain structure in adolescent obesity and 
the results of previous studies are contradictory. Furthermore, little is known about the 
correlation between brain structure and behaviour associated with childhood obesity. 
Therefore, we conducted a study to further elucidate this matter using MRI. The aim is to 
study whether adolescents with obesity differ in brain structures related with executive 
function and reward processing and whether differences, if found, associate with execu-
tive function and appetitive traits in obese and lean children.
MEthODs
study population
25 adolescents with obesity and 19 lean controls, as defined by the IOTF criteria(14), all 
of Caucasian origin, aged 12-16 years, were included in the study. Subjects with obe-
sity were recruited from our outpatient obesity clinic, control subjects were recruited 
from their peers and by local advertising. The aim was to have comparable groups on 
age, sex and education level. We excluded subjects with obesity caused by endocrine 
disorders (e.g. hypothyroidism) subjects with type II diabetes and subjects that used 
psychofarmaca (e.g. methylphenidate), or reported IQ <80. Furthermore, we excluded 
participants with MRI contra-indications; e.g. irremovable metal objects. The study pro-
tocol, P10.105, was approved by the medical ethics committee of the Leiden University 
Medical Centre. The study was registered in the Dutch Trial Register (www.trialregister.
nl) with number NTR2531.  All participants and their parents provided written informed 
consent.
Procedure
Subjects visited the hospital on two separate occasions. On the first visit, both neuro-
psychological tasks and a dummy scan session were performed. Parents were asked 
to fill out the CEBQ. Height and weight were measured using a calibrated stadiometer 
and scale. During the second visit the MRI scan was made as part of a scan protocol 
which also included an fMRI study (to be reported elsewhere). The mean amount of time 
between the first and second visit was 11 days (range 1-65 days).
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MrI acquisition and pre-processing 
MRI acquisition
Participants were scanned on a 3T MRI scanner using a 32-channel head coil (Philips 
Healthcare, Best, The Netherlands). Acquisition parameters were a repetition time (TR) of 
9.8 ms; echo time (TE) 4.6 ms; AP field of view (FOV) 224 x 224 mm; measured voxel size 
1.20 mm isotropic; flip angle 8°. Total scan duration was 5 min. 
MRI pre-processing 
The analysis of MRI scans was performed with FSL 5.0 (FMRIB Software Library)(15) and 
Freesurfer(16).  FSL-VBM was used to assess cortical thickness using a voxel-based mor-
phometry analysis. As a first step, images were brain extracted using the Brain Extraction 
Tool. Subsequently, FAST4 (FMRIB’s Automated Segmentation Tool) was used to carry 
out tissue-type segmentation. In the next step of the analysis grey matter partial volume 
images were aligned to standard space using FLIRT (FMRIB’s Linear Image Registration 
Tool), followed by nonlinear registration.  Averaging these images resulted in a study-
specific template. The native grey matter images were then non-linearly re-registered 
to this template. Correction for local contraction or expansion was applied by dividing 
partial volume images by the Jacobian of the warp field. The segmented modulated 
images were then smoothed with a 3 mm isotropic Gaussian kernel. Ultimately, a voxel-
wise general linear model was applied with non-parametric testing, using a correction 
for multiple comparisons across space (False Discovery Rate: 5%). 
To specifically assess subtler differences in cortical thickness possibly missed by 
VBM analysis a cortical reconstruction and segmentation in frontal and limbic regions 
of interest was performed using the Freesurfer analysis suite in conjunction with the 
Desikan-Killiany atlas. The Freesurfer suite is an extensively validated software tool for 
performing automated cortical morphometric measurements on T1-weighted anatomi-
cal MRI-scans. The orbitofrontal cortex, anterior cingulate cortex, insular cortex, frontal 
pole and superior, medial and inferior frontal gyrus were the regions of interest for our 
analysis. If Freesurfer provided sub parcelations of regions of interest; these were aver-
aged and then averaged between hemispheres.
FIRST (FMRIB’s Integrated Registration and Segmentation Tool) was applied to assess 
volumes of the subcortical twin structures amygdala, caudate nucleus, hippocampus, 
nucleus accumbens, pallidum, putamen and thalamus. This tool first registers all im-
ages to MNI152 templates, followed by fitting models for all different structures to the 
images. Finally, it performs boundary correction for volumetric outputs. FSLstats was 
used to calculate these volumetric outputs. Volumes of twin structures were averaged 
between hemispheres. 
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All segmentations performed were visually checked to determine if segmentation was 
performed correctly. In two male obese subjects segmentation was not performed cor-
rectly. Therefore, they were excluded from further analyses, leaving 23 obese and 19 
lean subjects.
Metabolic syndrome parameters
Presence of metabolic syndrome was added to our analysis, since it was shown that it 
might be a confounder in the relationship between obesity and structural differences(11). 
There are various definitions of metabolic syndrome. We used the IDF definition of ≥ 3 
of the following parameters: increased waist circumference, lowered HDL-cholesterol, 
increased levels of triglycerides, hypertension or elevated fasting glucose(17). Addition-
ally, we used HOMA-IR (> 3.4)(18) as a metabolic syndrome parameter instead of fasting 
glucose, since it has been posed to better correlate with presence of type II diabetes. To 
assess these parameters we used age and sex specific cut-offs for waist circumference 
sds (> p95)(19), HDL-cholesterol (< p5)(20), triglycerides (> p95)(20) and tension(21). 
neuropsychological evaluation
Child Eating Behaviour Questionnaire (CEBQ)
The CEBQ is a widely used questionnaire to evaluate various eating behaviour traits 
in children(22). We used the Dutch translation of this questionnaire(23). We used the 
‘enjoyment of food’, ‘food responsiveness’, ‘emotional overeating’, ‘desire to drink’ and 
‘satiety responsiveness’ subscales, frequently reported altered in childhood obesity (13), 
in this study. 
Neuropsychological tasks
Stop Signal Task: Inhibitory control was tested using a Stop Signal Task (SST). This task 
tests the ability of a subject to withhold a pre potent response and is extensively used 
to measure inhibitory control(24). In this task a square is presented on either the left or 
right side of the screen of a laptop computer. The subject has to indicate whether this 
so-called target was projected on the left or right side of the screen by pushing the right 
or left shift-button as fast as possible. In 25% of the trials the target is followed by an au-
ditory signal. In these trials subjects have to refrain from reacting to the target. The delay 
between appearance of the target and onset of the auditory signal varies as a result of 
successful or unsuccessful inhibition. The standard delay is 250 ms and after successful 
inhibition of the response the delay is increased by 50 ms. After unsuccessful inhibition, 
the delay period is decreased by 50 ms. The mean stop signal reaction time (SSRT) is the 
measure of interest in this study. SSRT is calculated by: “mean reaction time” - “mean stop 
signal delay”. Longer SSRT’s indicate that participants have poorer response inhibition. 
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Choice Delay Task: We investigated the ability to delay gratification with a Choice Delay 
Task (CDT). In this task participants are asked to choose twenty times between either 
one point or two points by clicking one of these choices on a screen. When they chose 
one point they received the point immediately, when they chose two points there was a 
delay of 30 sec. Subjects were told that with these points, they could get a gift and that a 
higher score increased the variety and size of gifts they could choose from. The number 
of large rewards was used for analysis. The task was preceded by five ‘practice rounds’ 
to familiarize participants with the extent of the delay when choosing the large reward. 
statistical analysis
All analyses were performed using SPSS 20.0.0. Student’s t-tests and chi square tests 
were used to explore the baseline characteristics. Mann-Whitney U tests were used 
to analyse between group differences in task- and questionnaire-based measures 
and are displayed as median and interquartile range. Between group differences in 
cortical thickness and subcortical volumes were analysed using general linear model-
ling, correcting for age and sex, and are displayed as means with standard error.  We 
regarded the comparison significantly different if the p-value was smaller than 0.05. 
We report on data uncorrected for multiple comparison as well as False Discovery 
Rate(FDR)-corrected p-values.  Furthermore, we investigated the relationship between 
found volumetric differences and metabolic syndrome parameters by linear regression 
analysis using single metabolic syndrome parameters, as well as metabolic syndrome as 
a whole, as an extra independent. Additionally, linear regression modelling was used to 
assess whether structural differences between lean and obese children associate with 
task- and-questionnaire based measures. Task- and questionnaire-based measures were 




Table 1 shows the baseline characteristics of the study groups and metabolic syndrome 
parameters in the obese group. There were no significant differences between groups 
on the confounding factors age, sex and education level.
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neuropsychological tasks and questionnaires 
The results of the between group comparison of neuropsychological tasks and question-
naires are shown in Table 2. Obese compared to lean children showed marginally lower 
scores on the CEBQ subscale ‘satiety responsiveness’ and significantly increased scores 
on the subscales ‘food responsiveness’ and ‘emotional overeating’ and had marginally 
higher scores on ‘enjoyment of food’. Furthermore, obese subjects performed marginally 
lower on the choice delay task. 
table 1 Baseline characteristics
Lean (n = 19) Obese (n = 23) p-value
female n (%) 9 (47) 14 (61) ns
age in years (sE) 14.5 (0.4) 15 (0.2) ns
Education level n (%) Lower 12 (63) 18 (78) ns
Middle 3 (16) 1 (4)
higher 4 (21) 4 (17)
BMI sds (sE) -0.08 (0.2) 3.54 (0.1) <0.001
hypertension (%) 9 (39)
hOMa-Ir > 3.4 (%) - 8 (35) -
Waist circumference > p95 (%) - 16 (70) -
hDL-cholesterol < p5 (%) - 5 (22) -
triglycerides > p95 (%) - 7 (30) -
average number of metabolic syndrome 
parameters per subject (sE)
- 1.96 (0.3) -
Presence of metabolic syndrome (%) - 10 (43) -
Table 1. Abbreviations: ns: not significant; BMI: Body Mass Index; HOMA-IR: homeostatic model assessment of 
insulin resistance; HDL: High-Density Lipoprotein. 
table 2 Results of neuropsychological tasks and questionnaires
Lean (n = 19) Obese (n = 23 ) p-value
Task-based measures
Mean stop signal reaction time ms (IQr) 256 (199-305) 253 (221-300) 0.90
Choice delay task number of large rewards (IQr) 14 (7-20) 10 (5-12) 0.07
Questionnaire measures
CEBQ satiety responsiveness (IQr) 2.6 (2.2-2.9) 2.3 (1.6-2.7) 0.063
CEBQ food responsiveness (IQr) 1.8 (1.6-2.2) 3.3 (2.4-3.7) < 0.001
CEBQ Enjoyment of food (IQr) 3.3 (3.0-3.6) 3.7 (3.2-3.9) 0.06
CEBQ Emotional Overeating (IQr) 1.6 (1.3-2.0) 3.0 (2.0-3.6) <0.001
CEBQ Desire to Drink (IQr) 2.3 (1.7-2.8) 3.0 (2.0-3.4) 0.17
Table 2. Data presented are median with interquartile range. Abbreviations: IQR: interquartile range, CEBQ: Child 
Eating Behavior Questionnaire.
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analysis of between group differences in brain structure
Voxel based morphometry showed no between group differences in cortical thickness. 
The between group analysis of cortical thickness in regions of interest showed no differ-
ences between groups (Table 3). Comparison of subcortical volumes showed that obese 
compared to lean subjects had larger pallidal volumes corrected for age, gender and 
FDR. Furthermore, at an uncorrected threshold, they had larger amygdalar volumes.
relationship of pallidal and amgydalar volumes and metabolic syndrome 
parameters
There was no relationship between presence of metabolic syndrome parameters or 
metabolic syndrome diagnosis and amygdalar or pallidal volumes in the obese group.







Orbitofrontal cortex  (sE) 2.90 (0.02) 2.83 (0.04) 0.21 0.49
anterior cingulate cortex  (sE) 3.20 (0.05) 3.17 (0.03) 0.78 0.97
frontal pole  (sE) 2.96 (0.06) 3.00 (0.07) 0.97 0.97
Inferior frontal gyrus  (sE) 2.93 (0.03) 2.92 (0.04) 0.86 0.97
Middle frontal gyrus  (sE) 2.75 (0.02) 2.71 (0.04) 0.61 0.85
superior frontal gyrus  (sE) 3.18 (0.03) 3.12 (0.04) 0.41 0.72




1.24 (0.03) 1.35 (0.04) 0.03 0.21
hippocampus
 (sE)
3.91 (0.06) 3.89 (0.09) 0.93 0.97
nucleus accumbens
m (sE)
0.50 (0.02) 0.54 (0.02) 0.12 0.42
Caudate nucleus
 (sE)
4.02 (0.09) 3.90 (0.07) 0.31 0.62
Putamen
 (sE)
5.01 (0.09) 5.24 (0.10) 0.19 0.49
Pallidum
 (sE)
1.65 (0.02) 1.78 (0.03) 0.001 0.014
thalamus
 (sE)
8.03(0.14) 8.25 (0.14) 0.11 0.42
Table 3. P-values presented are derived from general linear modeling corrected for age and sex. Abbreviations: 
SE: standard error, ns: not significant,, FDR: false discovery rate.
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analysis of pallidal and amygdalar volumes with appetitive traits and executive 
function
Analysis of the association between pallidal volumes and behavioural measures revealed 
a significant association between pallidal volumes and the number of large rewards in 
the Choice Delay Task in the obese group (p=0.012, adjusted for age and sex, Figure 1). 
We did not find this association in lean participants. Furthermore, we found a marginally 
significant negative relation between pallidal volumes and Stop Signal Reaction Time 
(p=0.055, adjusted for age and sex). So, increased pallidal volumes associated with bet-
ter inhibitory control and better ability to delay gratification within the obese group. 
These results were independent of the presence of metabolic syndrome. No associations 
were found between pallidum volume and appetitive traits or between the amygdala 
volume and any of the behavioural measures. 
DIsCussIOn
The results of this study show increased volume of the pallidum and amygdala in obese 
compared to lean adolescents, corrected for age, sex and FDR. Additionally, pallidal 
volumes were positively associated with inhibitory control and the ability to delay 
gratification. We did not find any differences between groups in the analyses of cortical 
regions, nor did we find an association between the neural structures and the metabolic 
syndrome.
figure 1
A: Example of the pallidum ROI in an obese participant; B: scatterplot of the relationship between pallidum vol-
ume and choice delay task performance in obese and lean subjects.
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The finding of increased pallidal volumes in obese compared to lean children is in 
accordance with recent findings in a group of 6-8 year old Mexican children(3). Further-
more, functional neuroimaging studies have shown that activation in the pallidum by 
high-calorie food images predicted BMI(25) and that reward sensitivity is associated 
with activation in the pallidum to appetizing food images(26). The ventral pallidum has 
been identified as possibly the most important structure in generating ‘liking’-signals 
(‘liking’ is defined as an objective behavioural or neural hedonic reaction to a stimu-
lus(27)). Therefore, our finding of increased pallidal volume might signal an abundance 
of endocannabinoid and opioid neurons responsible for ‘liking’, possibly contributing 
to increased intake of palatable food. Interestingly, we did not find an association with 
possible behavioural correlates of ‘liking’ as measured by the CEBQ (e.g. enjoyment of 
food), but with measures of executive function. Although it has been suggested that dif-
ferences in the pallidum in obese compared to lean children probably signal differences 
in reward processing(3), the pallidum is well known for being involved in inhibitory 
control by inhibiting activity of various reward structures via GABA-ergic inhibition(28). 
Furthermore, a recent study poses that neurons originating from the globus pallidus (i.e. 
dorsal pallidum) might directly influence frontal cortical areas implicated in inhibitory 
control(29), showing another possible mechanism how the pallidum might influence 
executive function. In conclusion, our data suggest an important role of the pallidum in 
the executive dysfunction described in childhood obesity.
The increased amygdalar volume found in obese compared to lean adolescents in 
this study is novel in childhood obesity. Increased size of the amygdala in adult obesity 
has been previously reported by our group(6). We have to stress, however, that this has 
to be replicated because a false positive result due to multiple comparison cannot be 
excluded. In the functional neuroimaging literature, the amygdala has been frequently 
implicated in food processing. For example, the amygdala is activated when processing 
food compared to non-food cues in healthy weight adolescents(30),  and activation is 
positively correlated with reward sensitivity(26). Therefore, we pose that the increased 
amygdalar volume found in obese compared to lean adolescents might indicate an in-
creased reward sensitivity, leading to increased intake of highly palatable foods. It has to 
be noted, however, that amygdalar volume did not associate with any of the predefined 
behavioural measures. 
Another interesting finding of this study is the lack of difference between groups in 
any of the predefined cortical regions. This is in contrast with some studies, that found 
reductions in the orbitofrontal cortex(4, 10, 11) and anterior cingulate cortex(11). This 
result is possibly explained by the relatively low prevalence of metabolic syndrome in 
our sample (< 50%), since recent studies suggest that reductions in cortical thickness 
might be caused by the harmful influence of the metabolic syndrome on the brain(11). 
Another possible explanation is that our sample is relatively young compared to most 
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cohorts describing cortical differences in obese compared to lean subjects. Therefore, 
the exposure of the obese adolescents in our cohort to adverse effects of metabolic 
syndrome parameters might have been too short to lead to cortical differences. 
There are strengths to consider in regard to this study. An important strength of our 
study is that the subjects in our cohort were equal on educational level, which ensures 
that differences found are not confounded by possible differences in intellectual 
capabilities. Furthermore, we corrected our findings on brain differences for multiple 
comparisons, showing that the differences found in pallidal volume are robust.
A possible limitation of the study is the choice to measure appetitive traits by means 
of a questionnaire instead of by a food laboratory measure. We argue, however, that 
within this age group, known food laboratory measures of behavioural traits are highly 
influenced by adolescents exhibiting socially desirable behaviour. Furthermore, we did 
not assess metabolic syndrome parameters in the lean group, making it impossible to 
correct the brain differences found between groups for this possibly confounding factor. 
However, in the regression model, exploring the effect of variance in pallidal volumes, 
we did correct for presence of metabolic syndrome parameters and did not find an ef-
fect. 
In conclusion, the results of this study show increased pallidal and amygdalar volumes 
in early adolescent obesity. Furthermore, we have shown an association between pal-
lidal volumes and executive function in the obese group, indicating an important role of 
the pallidum in executive dysfunction described in childhood obesity. 
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Adolescents with obesity differ from their lean peers in executive function, salience and 
reward processing. For these functions, it was shown that adults with obesity differ in 
functional brain connectivity with the corresponding salience and executive control 
networks, and with specific brain structures such as the amygdala and hypothalamus, 
even in an unstimulated state. Here, we investigate whether functional brain connectiv-
ity in adolescents with obesity differs from their peers in these areas.
Methods 
Seventeen adolescents with and 15 without obesity between the age of 12-16 years, 
matched for age, sex, and education were included in the study. Resting state fMRI was 
performed in a fed condition. Whole brain connectivity with the salience network, de-
fault mode network and executive control was assessed. Additionally, seed based analy-
sis was used to investigate connectivity of the amygdala, pallidum and hypothalamus. 
results 
Compared to lean subjects, subjects with obesity had increased connectivity of the sa-
lience network with the occipital pole and reduced overall connectivity in the executive 
control network, specifically within the lateral occipital cortex. 
Conclusion 
In an unstimulated and fed state, connectivity of visual processing areas networks 
involved in executive control and salience processing are altered in adolescents with 
obesity.
Differences in functional brain connectivity between adolescents with and without obesity in a fed condition 43
3
IntrODuCtIOn
Obesity at young age is a global problem (1, 2), leading to significant morbidity in 
early life, including hypertension, dyslipidaemia and glucose metabolism abnormalities 
(3). The complex, multifactorial nature of obesity makes it hard to treat. Over the last 
decades, genetic, social, neural and behavioural factors have been shown to have a 
complex interplay in the pathogenesis of obesity. In paediatric and adolescent popula-
tions, behavioural as well as neural correlates of obesity have been identified. One of the 
key behavioural aspects of this group is that they tend to eat in the absence of hunger, 
leading to overconsumption of food (4, 5). In this respect, impaired executive functions, 
such as inhibitory control and delaying gratification (6), increased sensitivity to the 
rewarding value of food (7), and decreased responsiveness to satiety signalling (8) have 
been posed to underlie overconsumption. 
Various differences in cerebral structure and function between youngsters with and 
without obesity have been described: Reduced volume and thickness of the anterior 
cingulate and orbitofrontal cortex (9), areas implicated in self-regulatory processes, 
were found in children with obesity. In contrast, volumes of areas related to reward pro-
cessing, such as the pallidum, were larger (9, 10). On functional level, areas associated 
with reward processing, such as the amygdala, were more active while viewing food-
related items in children with obesity than in lean children (11-13). Reward structures 
in the limbic system remained responsive to stimulation with food pictures after a meal 
in children with obesity, but not in lean children (11). This latter finding implicates that 
activity of the limbic system is continuously altered in children with obesity, even in a 
fed state and when not triggered by food stimuli. 
During fasting a stronger functional connectivity, determined with resting state fMRI, 
between the hypothalamus and the medial prefrontal cortex (14), dorsal striatum (14) 
and insula (15) was found in adults with obesity. Moreover, in persons with obesity, spe-
cific alterations in the default mode network have been described: Connectivity of the 
posterior cingulate gyrus, lateral inferior parietal cortex and precuneus was increased, 
whereas connectivity in the anterior cingulate cortex was decreased (16, 17). The default 
mode network is active during wakeful rest and when reflecting on one’s emotions and 
envisioning the future, and is mainly inactive when a person is actively engaging in an 
activity (18).  In addition to alterations in the default mode network, increased network 
connectivity in the salience network was found (19), a network involved in integration 
of homeostatic and salient signals.  These changes in both default mode and salience 
network indicate that, in adults with obesity, brain areas involved in reward- and sa-
lience processing, as well as areas involved in self-regulation are altered in a non-food-
triggered state. Although data on resting state connectivity in children and adolescents 
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with obesity could aid in understanding the behaviour of this group, these data are 
limited, warranting a more extensive exploration. 
To investigate potential changes in functional brain connectivity in the homeostatic 
and limbic system, and in the executive, salience and default mode network at rest in 
youngsters, we performed resting state fMRI in a case control study design, comparing 
adolescents with and without obesity, in a satiated state.
MEthODs
study population
Subjects with obesity, all Caucasian, were recruited from the obesity clinic in the Willem-
Alexander Children’s Hospital, according to the criteria stated by the International Obe-
sity Task Force (20). Lean control subjects were recruited from lean peers of the obese 
subjects, and via local advertising. We included subjects with obesity between the age 
of 12-16 years. The lean control group was matched on age, sex and education level. The 
educational system in the Netherlands from the age of 12 onward is subdivided into 
lower (‘VMBO’), middle (‘HAVO’) or higher education (‘VWO’) (21). Exclusion criteria were 
endocrine disorders, use of medication possibly affecting brain activity, mental retarda-
tion and wearing of irremovable metal objects potentially disturbing the fMRI signal. 
The medical ethics committee of the Leiden University Medical Center approved the 
study (P10.105) and all children and their parents provided written informed consent. 
The trial was registered under number NTR2531 (www.trialregister.nl).
Procedure
Subjects visited our centre on two separate occasions. During the first visit, weight and 
height were obtained using a calibrated scale and stadiometer. Subjects were familiar-
ized with MRI and MRI noises to reduce anxiety by use of a mock scanner. During the 
second visit, the fMRI scan was made in a satiated state, within two hours after breakfast. 
Hunger scores were obtained using a 9-point Likert scale. 
MrI acquisition
All subjects were scanned on a Philips Achieva 3.0 T scanner with an eight-channel 
SENSE head coil (Philips Healthcare, Best, The Netherlands). The resting state scans were 
acquired during a 7 min scan using a T2*-weighted gradient-echo echo-planar imaging 
(EPI) scan (acquisition parameters: EPI factor 35, repetition time (TR) 2.2 s, echo time (TE) 
30 ms, flip angle 80°, Field of View (FOV) 220 x 220 mm, measured voxelsize 2.75 mm 
isotropic, slice gap 0.275 mm). A high resolution T1-weighted MRI-scan (TR 9.8 ms; TE 
4.6 ms; AP FOV 224 x 224 mm; measured voxel size 1.20 mm isotropic; flip angle 8°) and 
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a high resolution T2*-weighted MRI-scan (TR of 2.2 s; a TE 30 ms; AP FOV 220 x 220 mm; 
measured voxel size 2 mm isotropic; flip angle 80°) were made for registration purposes.
MrI pre-processing and statistical analysis
Datasets were pre-processed and analysed using FSL version 5.0.9 (FMRIB’s Software 
Library, Oxford University) (22). Anatomical images and high-resolution functional 
images were brain-extracted using FSL’s BET-tool (23). The functional datasets were 
corrected for head motion using FSL’s MCFLIRT-tool (24) and smoothed using a 5 mm 
full-width-half-maximum kernel. Registration matrices were computed for linear and 
nonlinear registration of the functional data to MNI-space via each subject’s respective 
high-resolution functional and anatomical images (25). Secondary motion artefact re-
moval was performed using ICA-AROMA (0.3 beta), a data-driven method that employs 
independent component analysis and a pre-trained classifier working on a robust set of 
theoretically motivated features (26). The resulting denoised functional datasets were 
brain-extracted with the FSL-BET tool and registered to MNI-space using the previously 
computed registration matrices. Low frequencies were removed using a highpass filter 
with a 0.01 Hz cut-off value.
Statistics and processing
Differences in functional connectivity between adolescents with and without obesity, 
were evaluated for the default mode network, executive control network and salience 
network using the templates published by Smith et al (27). Analyses of connectivity of 
the hypothalamus, amygdala and pallidum were based on anatomically defined seed 
regions. The hypothalamus was chosen as a region of interest (ROI), given its central role 
in hunger and satiety sensing and the differential connectivity shown in adult obese 
subjects (12). The bilateral amygdala was chosen as a region of interest, given the dif-
ferential activation and connectivity in previous fMRI studies in subjects with obesity 
(12, 15). Furthermore, the pallidum was chosen, since we recently showed that subjects 
with obesity compared to lean subjects had larger pallidum volume and that pallidum 
volume correlated with executive function (10).  
The binary seed ROI were manually created on the MNI (Montreal Neurological Insti-
tute) template.  The hypothalamus ROI was defined using two spheres with a radius of 2 
mm at MNI coordinates: x = ±4, y = -2, z = -12, as previously identified (28) and used (29) 
by Küllmann et al. The bilateral pallidum ROI was defined by two spheres (which were 
slightly asymmetrical between left and right) with a radius of 3 mm at MNI coordinates 
x= -18, y= -4, z = -2 (left) and x = 20, y= -4, z= -2 (right). The bilateral amygdala ROI 
was defined by two (also slightly asymmetrical) spheres with a radius of 4 mm at MNI 
coordinates x = -24, y = -4, z = -18 (left) and x = 26, y = -4, z = -18 (right).
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Connectivity analysis were performed using FSL’s dual regression tool (30). Using this 
tool, subject-specific connectivity maps were generated for each network template and 
seed region. Each network template or binary seed region was evaluated in a separate 
model that also included two nuisance regressors based on conservative CSF and WM 
templates. In the first analysis, voxel wise Z-value measures of network connectivity were 
derived from the standardized parameter estimates that were produced during stage 2 
of the dual regression procedure. Using these Z-value maps, the mean within-network 
Z-value was computed for each network by averaging the values of the voxels within the 
network template, resulting in a measure of within-network connectivity per participant 
for each network. These measures were subsequently compared between groups using 
an independent samples Mann-Whitney- U-test. 
In a second analysis, the subject-level connectivity maps for each seed and network 
of interest, that resulted from stage 2 of the dual regression procedure, were tested for 
group-level differences, by means of a nonparametric two-sample whole brain T-test as 




A total of 37 subjects, 19 with obesity and 18 normal weight controls, were included in 
the study. The baseline characteristics of the cohort are shown in Table 1. There were 
no significant differences in sex, age and education level. Furthermore, there was no 
significant difference in reported hunger.  Five subjects were excluded from the analysis 
for various reasons. Two male participants of the normal weight group were excluded 
due to scanner related artefacts on their T1 weighted scans. One female participant from 
the group with obesity was excluded due to excessive motion. One female participant 
in the normal weight group had an unexpectedly large artefact due to a remnant of a 
dental brace. One male subject with obesity had unexpected symptoms of claustropho-
bia, which led to abortion of the study protocol. Therefore, a total of 32 subjects (17 with 
obesity and 15 lean) were included in the analysis. 
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functional connectivity of the predefined seeds and networks
Functional connectivity, within network as well as whole brain connectivity of the net-
work, was evaluated of the default mode network, the executive control network and 
the salience network. Additionally, connectivity was evaluated with three anatomically 
defined seed regions: the hypothalamus, the bilateral amygdala, and the bilateral pal-
lidum.
Description default mode network
For the default mode network, for entire group; with and without obesity combined, 
whole brain connectivity maps are shown in Figure 1A. Positive connectivity was found 
of the default mode network with frontal regions including the frontal pole, the supe-
rior frontal gyrus, orbitofrontal cortex and anterior cingulate cortex, in the thalamus, 
caudate nucleus and nucleus accumbens, and a posterior cluster, mainly covering the 
precuneous, lateral occipital cortex and occipital pole. Negative connectivity was found 
with the insular cortex, the primary and supplementary motor cortices and two smaller 
clusters in the lateral occipital cortex. No differences were found between lean subjects 
and those with obesity, neither in whole brain connectivity of this network nor in con-
nectivity within this network.
table 1 baseline characteristics
Lean (n = 15) Obese (n = 17) p-value
sex female (%) 7 (47) 9 (56) 0.73
age (sds) 15.0 (1.5) 15.0 (1.2) 0.92
BMI (sds) 18.6 (1.9) 35.1 (5.8) <0.001
BMI-sds (sds) -0.2 (0.8) 3.5 (0.5) <0.001
Education level Lower (%) 11 (73) 13 (76) 0.36
Middle (%) 3 (20) 1 (6)
higher (%) 1 (7) 3 (18)
hungerscale prescan (sds) 2.8 (2.1) 2.4 (1.6) 0.53
Table 1. Abbreviations: BMI: body mass index, sds: standard deviation score.
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Figure 1. Connectivity of the predefined seeds and networks in the cohort, from left to right in the X, Y and Z axis. 
A: Default Mode Network, B: Executive Control Network, C: Salience Network, D: Amygdala, E: Hypothalamus, F: 
Pallidum. Positive connectivity is thresholded at Z-score > 4 and shown in yellow/red; negative connectivity is 
thresholded at Z-score < -4 and shown in blue.
Differences in functional brain connectivity between adolescents with and without obesity in a fed condition 49
3
Description executive control network
Whole group connectivity maps for the executive control network are shown in 
Figure 1B. Positive connectivity was found with frontal structures including the frontal 
pole and anterior cingulate cortex. In addition, positive connectivity was found with 
the insular cortex and in the putamen and caudate nucleus. Positive connectivity was 
also found with posterior areas, including the middle temporal gyrus, superior parietal 
lobule, lateral precuneal cortex and lateral occipital cortex. Negative connectivity of 
the network was found with the superior frontal gyrus and orbitofrontal cortex, and 
posterior clusters comprising the posterior cingulate gyrus, medial precuneus and 
lateral occipital cortex. Subjects with obesity showed reduced connectivity within the 
executive control network (Table 2). More specifically, dual regression analysis showed 
that adolescents with obesity had reduced connectivity within the executive control 
network in two adjacent clusters in the right lateral occipital cortex (Figure 2A, Table 3).
table 2 Analysis of within network connectivity strength
Lean (n = 15) Obese (n = 17) p-value
salience network 1.22 (0.73-1.61) 1.05 (0.78-1.53) Ns
Default Mode network 1.53 (1.04-1.70) 1.37 (1.15-1.60) Ns
Executive Control network 1.57 (1.25-1.38) 1.33 (1.08-1.54) 0.044
Table 2. Comparison of the median of Z-scores(with interquartile range) between lean and obese participants. 
Abbreviations: ns: not significant.
Figure 2. Regions differing in connectivity between lean and obese subjects. A: the Executive Control Network; 
B: the Salience Network
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Description salience network
Salience network whole group connectivity maps are shown in Figure 1C. The network 
had positive connectivity with lateral clusters, including the insula, pre- and postcentral 
gyri, and posteriorly with the lateral occipital cortex, occipital pole and the lingual 
gyrus. Furthermore, positive connectivity with subcortical structures was found with 
the amygdala, putamen, thalamus, pallidum and brain stem. Negative connectivity was 
found with the frontal pole and superior frontal gyrus, and an occipitally with the lat-
eral occipital cortex. No differences were found analysing within network connectivity 
between subjects with and without obesity. Whole brain connectivity analysis showed 
increased connectivity of the salience network with a cluster in the left occipital pole in 
subjects with obesity (Figure 2B, Table 3). 
amygdala
In whole group analysis, the bilateral amygdala was positively connected to frontal 
regions including the frontal pole, anterior cingulate cortex, inferior and middle frontal 
gyrus and orbitofrontal cortex (Figure 1D). Within the basal ganglia it was connected 
with the putamen, hippocampus and thalamus. In addition, connectivity was found with 
the middle temporal gyrus, the lingual gyrus, and two large areas in the occipital lobe 
covering the occipital pole and the lateral occipital cortex. There were no differences in 
connectivity between subjects with and without obesity for these structures.
table 3 Regions exhibiting significant connectivity with predefined networks and seeds
hemisphere X Y Z
Cluster size 





R 48 -72 12 99 5.67 0.017
LOC
superior division
R 34 -80 30 85 4.49 0.033
Obese > lean
Salience network
Occipital pole L -12 -94 18 31 4.96 0.042
Table 3. regions of significant connectivity. X, Y and Z represent the MNI-coordinates of the voxel of maximal 
T-value of the cluster. T-value represents the maximal T-value of the cluster. Abbreviations: R: right, L: left. LOC: 
lateral occipital cortex.
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hypothalamus
Connectivity mapping in of the medial hypothalamus in the entire group (Figure 1E) 
showed connectivity to the anterior cingulate, paracingulate gyrus, nucleus accumbens, 
pallidum and brainstem. There were no differences in connectivity between subjects 
with and without obesity for these structures.
Pallidum
The pallidum whole group connectivity map (Figure 1F) showed connectivity with 
frontal regions including the frontal pole, anterior cingulate cortex, orbitofrontal cortex 
and the inferior, medial and superior frontal gyri, the insular cortex, putamen, thalamus 
and amygdala. Further connections included the lingual and supramarginal gyrus and 
superior parietal lobule. There were no differences in connectivity between subjects 
with and without obesity for these structures.
DIsCussIOn
In this study we show that, in a fed state, adolescents with obesity have lower resting 
state connectivity within the executive control network in the lateral occipital cortex, 
and have higher resting state connectivity of the salience network with the occipital 
pole. We did not find any differences in resting state connectivity of the amygdala, pal-
lidum, hypothalamus, and default mode network in whole brain analysis.
Our finding of adolescents with obesity showing lower within network connectivity in 
the executive control network, specifically in the lateral occipital cortex is of interest. The 
lateral occipital cortex is a structure involved in higher level visual processing, object 
recognition and visual attention (32), and has gained attention as an area involved in 
obesity pathophysiology. Obesity has been associated with reductions in volume and 
cortical thickness in the lateral occipital cortex (33-35). Although in normal weight 
subjects this area is activated by visual stimuli of high calorie foods (36) in subjects with 
obesity the lateral occipital cortex shows hypo-activity in response to food pictures 
(37). Furthermore, while viewing rewarding food and non-food items, subjects with 
obesity showed reduced connectivity in a frontal occipital network including the lateral 
occipital cortex (38). In addition, during this task, the lateral occipital cortex was con-
nected to fewer nodes and connections were weaker in subjects with obesity compared 
with lean subjects (39). It has been suggested that rewarding stimuli influence reward 
processing by recruiting more attentional resources towards these rewarding cues in 
people with obesity compared with lean people (39) with frontal brain regions exerting 
less control over these processes (40). Considering this hypothesis, it is of interest that 
a meta-analysis of studies on attention deficit hyperactivity disorder specifically found 
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lower activation in the lateral occipital cortex during executive function tasks (41), 
showing that this brain area is indeed hypoactive during executive functions in subjects 
with known deficits in executive function. Our results are in agreement with these data, 
and extend the literature by showing that, even at young age, obese subjects show de-
creased connectivity within a network involved in executive function, specifically in the 
lateral occipital cortex, even in an unstimulated state and in the absence of hunger. This 
poses the question whether this finding signals a constant vulnerability to food cues 
drawing attention and concomitantly triggering executive areas insufficiently, even 
when satiated, ultimately leading to overconsumption. To further investigate this, study 
designs aimed at investigating connectivity during executive function combined with 
food cues are needed. Furthermore, it would be interesting to apply subliminal food 
cues in the designs of these studies to investigate how food cues that obese subjects 
perceive without being aware (e.g. extensive food cues in the public domain) influence 
this connectivity. 
In addition to our findings of altered connectivity in the executive control network, 
obese subjects showed increased connectivity between the salience network and the 
occipital pole compared with lean participants. The salience network is a network that 
integrates salient with homeostatic signals; and alterations within this network have 
repeatedly been associated with obesity in adults, but also in children with Prader 
Willi syndrome (19, 40, 42). Previously it was shown that within the salience network, 
connectivity of the putamen was increased in subjects with obesity (19). In this paper 
it was proposed that this might signal an imbalance between autonomic and reward 
processes. Children with Prader Willi syndrome showed a generally increased connec-
tivity within the salience network, indicating widespread alterations in the processing 
of internal as well as external food cues (42).  However, this is a very specific group of 
subjects suffering from obesity with very specific feeding behaviour. Therefore, general-
izations of these findings to other subjects with non-syndromic obesity, should be made 
with caution. Most interestingly, and in line with our current findings, are recent data 
comparing connectivity of adults with and without obesity during a visual task with 
high-calorie, low-calorie and non-food pictures (40). It was shown that the connectivity 
of the salience network with a temporal-visual network, which includes the occipital 
pole, was increased in subjects with obesity. It did, however, not vary with caloric con-
tent of the food pictures, possibly indicating a more general preferential processing of 
visual food cues in subjects with obesity(40). Our data complement these findings by 
showing that, already at young age and in a fed- and resting state, obesity leads to an 
increased connectivity between a primary visual area and the salience network. It can 
be argued that this indicates a constantly present vulnerability to visual food cues being 
processed with priority.  
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We did not find differences in connectivity neither in the seed-based analysis of the 
amygdala, hypothalamus or pallidum, nor in default mode network connectivity be-
tween groups. However, it has been shown that in adults with obesity, connectivity in the 
default mode network, hypothalamus and amygdala are altered (14-17).  It is likely that 
these apparent differences are caused by differences in the level of brain development 
between the adolescent and a fully developed, adult brain. Moreover, our participants 
were scanned in a fed state, whilst other studies were almost exclusively performed in 
a fasting state. Possibly, these structures and networks show more pronounced differ-
ences in connectivity in obese subjects during fasting. 
A particular strength of the study is the matching on education level, since it reduces 
bias possibly introduced by differences in intellectual capabilities. A limitation of this 
study is the limited sample size, introducing type-2 errors, although this is usually the 
case in these studies as they are labour intensive. Furthermore, we were specifically 
interested in connectivity during the absence of hunger, so the results are limited by 
the fact that it only investigated subjects in a fed state. To gain insights in connectivity 
differences related to hunger, a fasting study could provide complementary insights. 
Additionally, we did not prospectively acquire data on metabolic parameters in our 
cohort, making it impossible to investigate whether our differences might be correlated 
with these parameters. 
COnCLusIOn
This study shows that, at young age, obesity is associated with a decreased network con-
nectivity within the executive control network, specifically in the lateral occipital cortex, 
and increased connectivity of the salience network in the occipital pole. This shows 
that even at rest and while satiated visual areas are differentially connected to areas 
implicated in salience- and reward processing and executive control in adolescents with 
obesity, possibly reflecting a constant vulnerability to food cues.
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Recently, the fat mass and obesity-associated gene (FTO) has been identified as a ge-
netic risk factor for developing obesity. The underlying mechanisms remain speculative. 
Recently, SNPs within FTO have been associated with brain atrophy in frontal and occipi-
tal regions, suggesting that FTO might affect body weight through cerebral pathways. 
Behavioural studies suggested a relationship between FTO and the reward-related be-
havioural traits. We therefore investigated the relationship between the FTO risk-allele 
rs9939609A and volumes of reward-related brain structures. 
Design and Methods 
492 Dutch individuals (56% males, age: 70 to 82 years) participating in the PROSPER-
study underwent a 3D-T1-w MRI to assess the volumes of reward-related brain struc-
tures (e.g. amygdala, nucleus accumbens) and of grey matter and white matter. Linear 
regression analysis was performed to test for the association of subcortical and cortical 
structures with rs9939609A. 
results 
rs9939609A is associated with lower volumes of the nucleus accumbens (p=0.03) and 
trended towards lower cortical grey matter volumes (p=0.08). This association is inde-
pendent of gender, age, and BMI, FDR corrected.
Conclusion 
The FTO risk-allele is associated with lower nucleus accumbens volumes, suggesting that 
the higher body weight of risk-allele carriers might be due to changes within reward-
related brain structures. 
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IntrODuCtIOn
For several years it has been known that alleles within FTO are associated with increased 
BMI. In 2007, Frayling et al. reported a risk allele, rs9939609A, within FTO, which was 
strongly associated with increased BMI. The per-A allele odds ratio for obesity was 1.31 
(95% CI 1.23-1.39; P = 6 x 10-16) and for overweight 1.19 (95% CI 1.13-1.24; P = 2 x 10-17), 
compared to the T allele(1). In the following years, numerous studies confirmed the as-
sociation between this and other single nucleotide polymorphisms (SNPs) within the 
FTO gene and BMI in various populations(2-4).
The FTO gene encodes a 2-oxoglutarate-dependent nucleic acid demethylase(5). 
Cell models have shown that overexpression of FTO reduces ghrelin mRNA N6-meth-
yladenosine and concomitantly increases ghrelin peptide levels. As such, it appears to 
play an important role in hypothalamic signalling of homeostatic hunger and satiation 
by influencing ghrelin production(6, 7). Furthermore, intronic variants within FTO have 
been shown to regulate expression of IRX3 in the hypothalamus, a gene well known for 
its role in the regulation of body mass and body composition(8).  These findings par-
tially explain the earlier reported changes in eating behaviour such as impaired satiety 
responsiveness and increased food intake in carriers of risk alleles(9-12).
Studies investigating the association between FTO and feeding behaviour traits, how-
ever, have also shown an association between FTO risk alleles and traits such as loss of 
eating control, emotional control, self-regulation and symptoms of ADHD. These traits 
have been found to be under the influence of reward-related brain structures(13-15). 
This poses the question whether FTO also influences reward-related brain structures.
The association between BMI and brain volume has been well described, especially 
in regions associated with the regulation of taste, reward, and eating behaviour(16-25), 
such as the hippocampus(22, 24), amygdala(20, 24), thalamus(22), (orbito)frontal 
structures(18, 21-23), and putamen(21). Moreover, a recent study indicated that FTO 
SNPs were also associated with regional brain volume changes using a tensor-based 
morphometric approach(17). 
The major aim of the present study was to investigate whether the FTO risk allele, 
rs9939609A, is associated with specific volume differences in the reward-system.
MEthODs
study population
Data were drawn from the nested MRI sub-study of the PROspective Study of Pravastatin 
in the Elderly at Risk (PROSPER). Of the 1,095 eligible Dutch participants for PROSPER, 
554 were randomly selected for MRI. Of these 554 subjects, 492 (56% males) had a suc-
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cessful MRI (i.e. successful  high resolution T1-w MRI scan, without excessive artefacts) 
and FTO gene analysis. Subjects undergoing an MRI exam did not differ in terms of age, 
gender, medical history and cardiovascular risk profile from the entire group.
PROSPER is a double-blind, randomized, placebo-controlled trial aimed at assessing 
the effect of pravastatin therapy on vascular events in subjects with vascular disease or 
at risk of vascular disease (26) in the elderly. Inclusion criteria for PROSPER were: age 70 
to 82 years; total cholesterol 4.0-9.0 mmol/L; or stroke, transient ischemic attack, myo-
cardial infarction, arterial surgery, or amputation for vascular disease >6 months before 
study entry; or ≥1 of the following risk factors for vascular disease: current smoker, 
hypertension (currently receiving drug treatment), or known diabetes mellitus or fasting 
blood glucose >7 mmol/L. (24). 
All data including MRI were recorded at baseline of PROSPER. The mean BMI at the 
time of intake was 26.8 kg/m2 (standard deviation=3.6). Systolic and diastolic blood 
pressure were recorded in a sitting position using a fully automatic electronic sphyg-
momanometer (Omron M4, Kyoto, Japan). None of the participants had been diagnosed 
with Minimal Cognitive Impairment (MCI) or Alzheimers Disease (AD) prior to the first 
visit as was established by extensive questioning of their medical history. Furthermore, 
subjects underwent a Mini Mental State Examination (MMSE)(27), and were excluded 
from PROSPER if MMSE <24 at baseline. All participants gave written informed consent.
MrI acquisition
All analyses in this study were based on 3D-T1-weighted gradient-echo MRI scans ob-
tained at 1.5T (Philips Medical Systems, Best, The Netherlands). Acquisition parameters 
were: repetition time (TR) = 30 msec; echo time (TE) = 4.6 msec; flip angle = 30°; slice 
thickness = 1.5 mm; 120 slices; no interslice gap; field of view (FOV) = 220 x 220 mm, and 
a matrix size of  256 x 256. 
MrI post-processing and analysis
All MRI scans were analysed using different tools of FSL (FMRIB Software Library)(28, 
29). Whole brain volume, grey and white matter volumes were calculated using the 
FSL- SIENAX tool (Structural Image Evaluation, using Normalization, of Atrophy). SIENAX 
starts by extracting brain and skull images from the single whole-head input data. 
The brain image is then affine-registered to MNI152 space, using the skull image to 
determine the registration scaling. This is done in order to obtain the volumetric scaling 
factor, to be used as a normalization for head size. Tissue-type segmentation with partial 
volume estimation is performed to calculate the total volume of brain tissue, including 
separate estimates of grey matter and white matter volumes. 
To assess local differences in cortical thickness, FSL-VBM, a voxel-based morphometry 
analysis was performed. First, structural images were brain-extracted using the Brain 
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Extraction Tool. Subsequently, tissue-type segmentation was carried out using FAST4 
(FMRIB's Automated Segmentation Tool). The resulting gray matter partial volume 
images were aligned to MNI152 standard space using the affine registration tool 
FLIRT (FMRIB's Linear Image Registration Tool), followed by nonlinear registration. The 
resulting images were averaged to create a study-specific template, to which the native 
gray matter images were non-linearly re-registered. To correct for local expansion or 
contraction, the registered partial volume images were modulated by dividing them 
by the Jacobian of the warp field. The modulated segmented images were smoothed 
with an isotropic Gaussian kernel with a sigma of 3 mm. Finally, a voxel-wise general 
linear model was applied using permutation-based non-parametric testing, correcting 
for multiple comparisons across space (False Discovery Rate: 5%).
To determine the volume of the brain stem and the volumes of the subcortical twin 
structures nucleus accumbens, amygdala, caudate nucleus, hippocampus, pallidum, 
putamen and thalamus, FMRIB’s Integrated Registration and Segmentation Tool (FIRST) 
was used. FIRST starts by registering all images to MNI152 templates. It then fits models 
for all different structures (meshes) to the images, and finally applies boundary correc-
tion for the volumetric output.
Genetic analysis
The genotyping of the FTO rs9939609 polymorphism [intronic nucleotide substitu-
tion T>A; reported global minor allele frequency 0.34, [http://www.ncbi.nlm.nih.gov/
projects/SNP] was carried out using real-time PCR with TaqMan SNP Genotyping Assays 
from Applied Biosystems (Foster City, California, USA) at the Tufts University in Boston. 
The minor allele frequency in our cohort was 0.38, which is in accordance with various 
European populations reported previously(1, 3, 30). Genotyping success rate for the 
entire cohort was 99.1%. χ2-testing was performed to see whether our population was 
within Hardy-Weinberg equilibrium for rs9939609.
statistical analysis of baseline data 
If not otherwise stated, data are presented as mean with standard error (SE). Medical his-
tory was established via a questionnaire prior to the first visit. Chi-square tests were used 
to test for differences in gender, history of hypertension, history of vascular disease, his-
tory of myocardial infarction (MI) or history of diabetes mellitus (DM) between groups. 
statistical analysis of relationship between genotype and reward related brain 
structures
For all continuous variables regression analysis was used. A linear regression model was 
used to assess the association of various brain tissue volume measurements with TT, TA 
and AA subgroups. In model 1, we corrected for age and gender. To exclude the effects 
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of BMI on brain structures, we additionally added BMI as a covariate (model 2). We cor-
rected for multiple comparisons using a False Discovery Rate approach for both models. 
For all statistical analyses, SPSS software for windows (version 20.0.0.1; SPSS) was used. 
rEsuLts
Genetic testing
The FTO rs9939609 polymorphism’s minor allele (A) frequency (MAF) was 0.38. The FTO 
TT variant was found in 185 of the 492 subjects (38%), the TA variant was found in 236 
of the 492 subjects (48%), and the AA variant was found in 71 subjects (14%). Hardy-
Weinberg equilibrium (HWE) testing using a χ2-test showed that rs9939609 was in HWE 
(HWE = 0.09, P = 0.760). 
Table 1 shows all demographic data for the various FTO genotypes. No difference in 
age and gender was found between groups. Subjects homozygous for the FTO risk allele 
A demonstrated a significant higher BMI, corrected for age and gender, compared with 
subjects with the T allele. No difference in either systolic nor diastolic blood pressure 
was found between groups. There was also no difference in history of hypertension, 
vascular disease, MI or DM between the three groups. 
table 1. Baseline characteristics
ftO rs9939609ta polymorphism
P-valuett (n=185) ta (n=236) aa (n=71)
Gender female n(%) 82 (44) 107 (45) 29 (41) 0.80
Age (years) 74.6 (0.2) 74.4 (0.2) 74.4 (0.4) 0.77
BMI (kg/m2) 26.6 (0.3) 26.6 (0.2) 27.9 (0.5) 0.015
Systolic BP (mmHg) 157.2 (1.6) 157.4 (1.3) 159.9 (2.8) 0.65
Diastolic BP (mmHg) 85.5 (0.8) 85.9 (0.7) 87.1 (1.3) 0.55
History of vascular disease n(%) 75 (40) 97 (41) 35 (49) 0.41
History of MI
n(%)
23 (12) 29 (12) 7 (10) 0.83
History of hypertension
n(%)
108 (58) 151 (64) 47 (66) 0.38
History of DM
n(%)
31 (17) 47 (20) 7 (10) 0.14
Table 1: Abbreviations: MI= Myocardial infarction, DM= Diabetes Mellitus, BMI=Body Mass Index, BP=Blood 
pressure.
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relationship reward-related brain structures and ftO  
Table 2 shows the volumetric data for all FTO mutation variants. Of all subcortical struc-
tures the nucleus accumbens demonstrated a gradual 12% decrease in volume from TT, 
0.59 ml, to AA, 0.52 ml (p = 0.04 adjusted for age and sex, and FDR corrected for multiple 
comparisons). This association remained significant when additionally adjusting for BMI 
(p = 0.03). No subcortical volume changes between the FTO groups were found for the 
hippocampus, amygdala, caudate nucleus, pallidum, thalamus, and putamen.
Furthermore, we found a small (1.2%) decline in the volume of the cortical gray 
matter from TT to AA, which trended towards significance (p = 0.08, corrected for age, 
sex and BMI, and FDR corrected for multiple comparisons). To assess regional differ-
ences in cortical thickness in contrast to overall volumetric changes, VBM (voxel-based 
morphometry) analysis was performed; this did not reveal any significant focal cortical 
differences among groups. No difference between groups was found for white matter 
volume reduction.
DIsCussIOn
The results of this study show that the risk allele rs9939609A of the FTO gene is associ-
ated with a significantly lower volume of the nucleus accumbens and trended towards 
table 2. Volumes and association of different brain volumes with FTO.
ftO rs9939609ta polymorphism Model 1
P-value
model 2
P-valuett (n=185) ta (n=236) aa (n=71)
Grey matter
(ml) 
469 (4) 464 (4) 463 (7) 0.012 0.017
White matter
(ml)
604 (4) 607 (5) 605 (4) 0.73 0.86
Hippocampus
(ml)
4.68 (0.04) 4.58 (0.04) 4.69 (0.06) 0.48 0.37
Amygdala
(ml)  
2.02 (0.02) 1.97 (0.02) 2.05 (0.04) 0.90 0.75
Nucleus caudatus (ml) 3.79 (0.04) 3.74 (0.04) 3.77 (0.06) 0.55 0.58
Nuc. accumbens (ml) 0.59 (0.01) 0.55 (0.01) 0.52 (0.02) 0.004 0.003
Pallidum
(ml) 
1.93 (0.03) 1.94 (0.03) 1.95 (0.05) 0.81 0.88
Thalamus
(ml) 
8.10 (0.05) 8.04 (0.05) 8.12 (0.09) 0.62 0.53
Putamen
(ml) 
5.24 (0.04) 5.18 (0.04) 5.34 (0.08) 0.56 0.54
Table 2: Data are presented as Mean (SE). MODEL 1: Linear regression correcting for gender and age; MODEL 2 
Linear regression correcting for gender. age and BMI.
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a smaller cortical grey matter volume. This association is independent of gender, age 
and BMI in this cohort. Although other studies have shown global grey matter volume 
differences with the FTO gene or BMI, to our knowledge, this is the first study to identify 
specific brain structures within the reward system that are affected by the FTO gene. No 
association between FTO and other subcortical brain structures was found. 
Very little is known about the relationship between the FTO gene and the nucleus ac-
cumbens. There is, however, more known about the role that FTO plays in hypothalamic 
signalling. Research in chickens, mice and rats has shown expression of FTO throughout 
the brain with high expression in the hypothalamus (5, 31-34). The hypothalamus has an 
influence on the nucleus accumbens through dopaminergic projections via the ventral 
tegmental area. 
The nucleus accumbens is a brain structure with a central role in the reward circuitry. It 
has a role in motivation-related behaviour, reward, and the craving of various substances 
including food(35, 36), and has a regulating role in dopaminergic signalling to the 
output-structures of the reward-system(37). The activity of the hypothalamus - nucleus 
accumbens pathway has recently been shown to be up-regulated by ghrelin and down-
regulated by leptin, hormones known to be important for the regulation of homeostatic 
hunger(36). A study by Karra et al. revealed that healthy subjects with a normal weight 
with genotype AA at SNP rs9939609 have attenuated post-prandial ghrelin suppression 
(7) compared to subjects with a normal weight with genotype TT at SNP rs9939609. 
Furthermore, this study showed that the response to hedonic food pictures was dif-
ferentially modulated between AA and TT phenotypes in the nucleus accumbens(7). In 
addition it was shown that knockout of FTO in mice impairs dopamine receptor type 2 
and 3-dependent control of neuronal activity and behavioural responses(38). 
Another possible mechanism through which FTO might have an influence on reward 
signalling is by regulating the expression of IRX3. This gene has been implicated in 
regulating body weight and is expressed in the hypothalamus, amygdala and caudate 
nucleus, all of which connect with the nucleus accumbens(8). 
Our data, showing a lower nucleus accumbens volume in people with the FTO AA 
genotype, support the hypothesis that subjects with the FTO AA gene have attenuated 
regulation of dopaminergic projections to the nucleus accumbens and through that to 
the output-structures of the reward-system leading to the previously mentioned differ-
ences in feeding behaviour between FTO TT and FTO AA. 
Our study also showed a trend line effect of the FTO polymorphism on the total volume 
of grey matter. The relationship between SNPs within the FTO gene and brain volume 
deficits has been previously reported in populations of elderly subjects (17) as well as in 
adolescents(39). It has been suggested that the effect of FTO on brain volume deficits 
probably originates in developmental stages of life, given that it is already apparent in 
adolescence. It was suggested that there might be an inverse relationship between FTO 
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and brain tissue compared to the relationship between FTO and adipose tissue(39). The 
findings of our study support these results, showing a trend line association between 
the presence of the FTO risk-allele and increased cortical brain atrophy (39). Since 
it was previously shown that BMI was not associated with lower nucleus accumbens 
volumes(22, 24), our finding that FTO is specifically associated with lower nucleus ac-
cumbens volumes indicates that the underlying cerebral process associated with BMI 
and brain atrophy is different. 
However, our data do not support the results of a recent study by Cole et al.(40) show-
ing that only BMI, and not FTO, was associated with brain atrophy. In this study younger 
subjects with a different SNP (rs3751812) were included(40). Still, our data unequivocally 
show that the association between the FTO polymorphism and brain volume deficits is 
independent of BMI. 
The major limitation of this study is that we included elderly subjects with an in-
creased cardiovascular risk profile. Though we did not find differences in cardiovascular 
risk profiles between the FTO polymorphism groups, our data may not be generalizable 
to a healthy population. 
COnCLusIOn
In conclusion, the results of our study support previous research stating that FTO is 
associated with brain volume deficits as well as studies stating a role for FTO in dopami-
nergic signalling within the reward-system. Further research should focus on functional 
imaging of the reward system and the relationship with FTO to determine whether the 
differences in reward-related brain structures are a result of altered hypothalamic signal-
ling or an independent effect of FTO on reward-related brain structures.
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Childhood obesity is associated with advanced bone age (BA). Previous studies suggest 
that androgens, oestrogens, sex hormone binding globulin and insulin are responsible 
for this phenomenon, but results are contradictory and might be biased by confounders. 
We aim to elucidate this matter by applying a multivariate approach.
Method 
We performed a correlation analysis of BA standard deviation score (SDS) with age and 
sex specific SDS for androgens, oestrogens, and with indicators of insulin secretion 
derived from oral glucose tolerance testing, in a group of  obese children. A multivariate 
analysis was performed to investigate which parameters were independently predictive 
of BA SDS. 
results 
In this cohort (n=101; mean age 10.9 yrs; mean BA 11.8 yrs; mean BMI SDS 3.3), BMI 
SDS was significantly correlated to BA SDS (r=0.55, p< 0.001). In a regression analysis 
in the total cohort (B=0.27, p<0.001), as well as in females (B=0.34, p=0.042), males 
(B=0.31, p=0.006) and pubertal children (B=0.32, p=0.046), DHEAS showed a positive, 
independent association with BA SDS. No association with indicators of insulin secretion 
was found. 
Conclusion 
BMI SDS is highly correlated to BA SDS in obese children. Increased DHEAS has a central 
role in advanced bone age in obese children.
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IntrODuCtIOn
The worldwide increase in overweight and obese children has led to significant mor-
bidity, including type 2 diabetes, cardiovascular diseases, fatty liver disease, impaired 
development and psychological problems (1). Furthermore, children with excess weight 
have been reported to have accelerated sexual maturation and linear growth, often 
accompanied by an advanced bone age (BA), and a decreased pubertal growth spurt, 
compared to normal weight children (2-4). The mechanism driving this BA advance-
ment, however, has remained unclear. 
Various alterations in hormone levels have been proposed to be responsible for this 
phenomenon, such as androgens (5-8), oestrogens (5-7, 9) and sex hormone binding 
globulin (SHBG) (7). Furthermore, two recent studies have indicated that increasing in-
sulin resistance and insulin secretion are associated with BA advancement (10, 11). These 
studies, however, vary widely in study design and outcome parameters investigated, 
and led to contradictory results. For example, some studies evaluated the difference 
between BA and calendar age (CA) (8, 10) whereas others assessed the ratio between 
these parameters (11), while an age-adjusted indicator would theoretically be superior. 
Furthermore, some studies included prepubertal children only (6, 10), while others 
also included pubertal children (5, 7). Additionally, most studies reported on androgen 
and oestrogen levels as absolute levels, although these vary significantly with age and 
pubertal staging, making age an important potential confounder in association studies. 
Finally, various factors are expected to be mutually dependent. 
Therefore, we investigated the multivariate relationship between BA standard devia-
tion score (SDS) for age and sex versus age- and sex-adjusted serum concentrations of 
serum androgens, oestradiol, SHBG (expressed as SDS) and indicators of insulin secre-
tion in a cohort of prepubertal and pubertal obese children. 
MEthODs
study cohort
Obese children visiting our obesity clinic between January 2012 and July 2015, in 
whom BA assessment and an oral glucose tolerance test (OGTT) were performed, were 
included into this retrospective cohort study. The OGTT, BA assessment and endocrine 
measurements were, at that time, part of an extensive diagnostic package which we 
performed as standard care for all obese children. The aims of this diagnostic approach 
were a) early detection of glucose metabolism abnormalities and other complications 
of obesity such as polycystic ovary syndrome (PCOS) and b) detection of endocrine or 
genetic causes of obesity. Exclusion criteria for this study were endocrine disorders (e.g. 
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hypothyroidism), syndromes known to affect insulin sensitivity or increased skeletal 
maturation BA (e.g. Bardet-Biedl syndrome or overgrowth syndromes), medication af-
fecting insulin sensitivity or skeletal maturation (e.g. metformin or methylphenidate), 
missing fasting insulin or unreliable OGTT data (e.g. due to vomiting or problems with 
i.v. catheter) and missing BA SDS (e.g. outside age reference range of BoneXpert). In this 
cohort, patients with marked hyperphagia and early onset obesity (onset of obesity < 
5 years of age) were tested for genetic causes of obesity by means of a genetic panel 
developed at the University Medical Centre in Utrecht. It tests for 53 genes known to 
cause monogenic obesity. Patients with genetic defects indicating monogenic obesity 
were included in this study, since there is no reason to assume that their BA is affected in 
any other way than in other obese children. The results for these patients are shown with 
specific symbols in the figures. The study was approved by the medical ethics committee 
of the Leiden University Medical Center and conducted within the terms of declaration 
of Helsinki. Since all participants received standard of care only, subject consent was 
waived.
anthropometric data and definitions
At the first visit, height and weight were measured using a stadiometer and calibrated 
scale, respectively. Obesity and BMI SDS were determined using the International Obe-
sity Taskforce criteria (12). Height SDS was determined based on the Dutch nation-wide 
growth study performed in 2009 (13). Modified Tanner staging (14) was performed to 
determine pubertal stage (Tanner stage >G1 in males or >B1 in females were scored as 
pubertal).   
Ba evaluation
We used BoneXpert to determine BA and BA SDS on a radiograph of the left hand (15). 
BoneXpert is a fully automated system based on an extensive database, which deter-
mines the Greulich and Pyle BA by analysing 15 bones of the left hand and wrist (15, 
16).  BoneXpert is validated to determine BA and associated SDS in males of 2.5-17 years 
old and in females of 2-15 years for different ethnicities (15, 16). We used Caucasian 
as standard reference, since our cohort was largely Caucasian and the non-Caucasian 
participants were of north African and middle eastern descent, for which BoneXpert 
does not provide ethnicity-specific SDS. The radiographs were made on the date of the 
first visit, or during the visit for oral glucose tolerance testing. 
Oral Glucose tolerance test procedure
OGTT was performed after an overnight fast with a minimum of 10 hours. A standardized 
dose of oral glucose of 1.75 gram/kg, with a maximum of 75 gram, was administered at 
the beginning of the test. An intravenous catheter was used to collect the blood samples 
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at t = 0, 30, 60, and 120 minutes. These samples were analysed for insulin and glucose 
concentrations. An extra sample to measure concentrations of oestradiol (E2), testoster-
one (T), androstenedione (Adione), dehydroepiandrosterone sulphate (DHEAS), and sex 
hormone binding globuline (SHBG) was obtained at t=0.
Laboratory measurements
Blood samples were analysed in the clinical laboratory of the Leiden University Medical 
Center (LUMC, the Netherlands). Immulite 2000 XPi (Siemens Healthcare Diagnostics, 
Tarrytown NY, USA) immunoassays were used to determine the serum concentrations of 
insulin (mU/l), SHBG (nmol/l), and DHEAS (umol/l). T (nmol/l) was analysed by immunoas-
say (ECLIA) on a Roche Modular E170 immunoanalyser, Adione (nmol/l) was analysed us-
ing a radioimmunoassay of Beckman Coulter (formerly DSL, Woerden, the Netherlands). 
Glucose was analysed in serum using a hexokinase method on Roche Modular P800 
chemistry analyser. Two different but compatible methods, the automated ECLIA assay 
of Roche and the Orion ultra-sensitive RIA, were used to measure the E2 levels (pmol/l). 
Concentrations of the Orion RIA method were converted to ECLIA by a conversion factor. 
Due to the retrospective nature of this study, using data obtained in standard care, no 
mass spectrometry measurements were available for estradiol and testosterone. The 
Roche testosterone (generation 2) and estradiol generation 2 assays are state of the art 
immunoassays with limits of detection of 0.09 nmol/l and 18.4 pmol/l respectively. Both 
assays have been standardized against international reference methods (ID-GCMS). The 
Orion ultrasensitive RIA for estradiol had a similar limit of detection with excellent cor-
relation in comparison with the Roche assay.
Concentrations of measured outcomes under the detection limit were defined as the 
mean between the lower detection limit of the test and zero. The Homeostatic Model 
Assessment of insulin resistance (HOMA-IR) was calculated using the formula: T0 glucose 
(mmol/l) x T0 insulin (mU/l) / 22.5 (17). We calculated the area under the curve for insulin 
levels during the OGTT using the trapezoid method.  
Conversion of serum steroid levels to standard deviation scores
In order to estimate the possible influence of serum SHBG, E2 and steroid levels on BA 
advance, we converted patients’ serum levels to SDS, based on published reference 
values using the same assays. Since the age distribution is skewed, for each age interval 
separate SD values were calculated above and below the mean. Values for +1 SD and -1 
SD were estimated by dividing the difference between P97.5 and P50 and the difference 
between P50 and P2.5 by 1.96, respectively, as previously described (18). For DHEAS and 
SHBG we used the age and sex specific centiles provided by Elmlinger et al. (19). 
Reference data for T and E2 were derived from the Caliper database (20). For these 
parameters, we calculated SDS only for children ≥9.0 years of age, since the reference 
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values for children below 9 years of age were largely below the detection limit. For 
children ≥9.0 years with plasma concentrations below the detection limit we imputed 
the data by dividing the lower detection limit by 2. We used the data from the Caliper 
database to directly calculate 1SD and -1SD scores in different age groups. 
For DHEAS, SHBG, T and E2 smoothed-fit lines of the -1SD, P50 and 1SD data points 
were created, providing an equation to calculate age- and sex-adjusted SDS for these hor-
mones: (serum concentration – age specific P50)/(age specific -1 or +1SD); SDS(X)=([X]-
P50)/SD. There were no reference data applicable for our assay for serum insulin and Adi-
one, so these concentrations in our patients could not be expressed as SDS. The results of 
smooth-fitting and plots of SDS scores in our cohort are summarized in the supplemen-
tary figures; SHBG SDS (supplementary figure 1), DHEAS SDS (supplementary figure 2), T 
SDS (supplementary figure 3), E2 SDS (supplementary figure 4).   
statistical analysis
All analyses were performed using IBM 23.0 SPSS Statistics. We performed analyses for 
the total cohort, as well as for subgroups based on sex and puberty. Normality was tested 
using the Kolmogorov-Smirnov and the Shapiro-Wilk Test (p > 0.05 was considered nor-
mally distributed). We report on mean and SD and median with interquartile range (IQR) 
for Gaussian and non-Gaussian distributed data, respectively. For the various SD-scores 
we investigated whether they significantly differed from zero using one-sample t-tests 
or a one sample Kolmogorov-Smirnov test. Correlation analyses were performed using 
Pearson and Spearman correlations depending on normality. 
First, we performed correlation analyses exploring the possible effect of age and BMI 
SDS on the various parameters possibly influencing BA. We then investigated the cor-
relation of these parameters with BA SDS. In both analyses, we report on significant 
correlations (p<0.05).
As a last step, we investigated which parameters were independently associated with 
BA SDS using backward regression analyses, using the pairwise exclusion option in SPSS. 
In a model with BA SDS as the dependent variable we entered age, sex, DHEAS SDS, 
SHBG SDS, fasting insulin, HOMA-IR and AUC insulin and investigated independent rela-
tionships to BA SDS in the total cohort and subgroups split on sex and puberty. E2 SDS 
and T SDS were only entered in the model for the pubertal subgroup, since they were 
unavailable for most prepubertal subjects. We tested the assumptions of each model 
by checking the independence of the residuals (Durbin-Watson test), inspecting their 
homogeneity (inspection of the scatterplot) and testing their normality (Kolmogorov-
Smirnov test > 0.05).




Out of the 184 children that visited the Willem-Alexander Children’s Hospital 101 children 
met the inclusion criteria for this study. Figure 1 summarizes the reasons for exclusion of 
the remaining subjects. Baseline characteristics are presented in table 1. The cohort had 
a mean age of 10.9 years and a mean BA of 11.8 years resulting in a mean BA SDS of 1.2; 
57 % of the children were pubertal, and 47% female. Mean height SDS was 0.6 and mean 
BMI SDS 3.3. Mean BA SDS and DHEAS SDS were increased (both p<0.001), while T SDS 
and SHBG SDS were decreased versus age references (p= 0.032 and 0.003, respectively). 
n=184 Visited the clinic 
31 children excluded due to 
being overweight  no 
OGTT 
n=153 OGTT data and 
BA assessment 
25 children excluded for 
missing BA-SDS  because 
age was outside the 
reference range of 
BoneXpert 
n=128 with BA-SDS 
19 OGTTs were partially 
missing (e.g. missing fasting 
sample) or unreliable (e.g. 
vomiting) 
n=109 with complete 
OGTT data and BA-SDS 
5 children excluded for 
usage of Methylphenidate 
1 child excluded for usage 
of Metformin 
1 child excluded for 
hypothyroidism 
1 Child excluded for 
overgrowth syndrome 
n=101 included in the 
study 
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In five subjects of the final cohort, a genetic mutation was found. Two male subjects 
showed a heterozygous MC4R mutation (Cys293Tyr and Ile251Leu) and one male sub-
ject showed a heterozygous mutation in WDPCP (Leu379Ser). Furthermore, one female 
subject showed a heterozygous, mutation in BBS7 (Gln365Leu), while another female 
subject was found to have two heterozygous variants in CEP290 (Ile1059fs) and MKKS 
(Ala242Ser). 
Correlation between outcome parameters and age or BMI sDs
The correlation analysis of the outcome parameters with age and BMI SDS are presented 
in table 2 and scatterplots are shown in Figure 2. The data are presented as Pearson 
correlation or Spearman’s ρ, where applicable. BMI SDS was negatively correlated with 
age in prepubertal children and positively in pubertal children, showing a U-shape over 
the whole age range (Fig. 2A). 
The insulin parameters in the total cohort as well as in subgroups according to sex 
and puberty showed a positive correlation with age. T SDS showed a significant nega-






R2 Linear = 0.087 D R2 Linear = 0.307 
Figure 2. A: association between BMI SDS and age (years); B: association between bone age (years) and chrono-
logical age (years); C: association between bone age SDS and age; D: association between bone age SDS and BMI 
SDS. Abbreviations: SDS: standard deviation score; BMI: body mass index; R2: Coefficient of deviation. Squares 
represent males, x represent females, bold circles represents males with monogenetic obesity, bold stars repre-
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negatively correlated with age (ρ = -0.38), in contrast to a positive correlation with age 
(ρ = 0.35) for DHEAS SDS. 
Fasting insulin (ρ = 0.28), HOMA-IR (ρ = 0.28) and AUC insulin (ρ = 0.42) showed a 
significant positive correlation with BMI SDS in the pubertal subgroup. BMI SDS showed 
a trend toward a positive correlation with DHEAS SDS in the whole cohort and pubertal 
subgroup. In contrast, there was a trend toward a negative correlation with SHBG SDS in 
the whole cohort, which reached statistical significance in the pubertal subgroup. 
Correlation between Ba sDs versus clinical and biochemical parameters 
Figure 2B shows that in the great majority of patients BA is advanced. As shown in 
table 3 and Fig 2C, BA SDS is relatively more advanced in young children: there was a 
significant negative correlation between BA SDS and age in the total cohort (r = -0.29) 
as well as in subgroups split on sex (female r = -0.31, male r = -0.41). BMI SDS showed 
a strongly significant correlation with BA SDS in the total cohort (ρ = 0.55) (figure 2D), 
as well as in female (ρ = 0.49), male (ρ = 0.55), prepubertal (ρ = 0.52) and pubertal (ρ = 
0.51) subgroups. 
Correlations between BA SDS and biochemical variables are presented in table 3. In 
females, T SDS showed a positive correlation with BA SDS (ρ = 0.44). In the total cohort, 
as well as in the male and both puberty subgroups, DHEAS SDS showed a positive cor-
relation with BA SDS. SHBG SDS was negatively associated with BA SDS, particularly in 
pubertal children (ρ = -0.31). The insulin parameters and E2 SDS did not show significant 
correlations with BA SDS in the total cohort, nor in any subgroup.
table 3. Correlation between bone age SDS and clinical and biochemical variables
total cohort
sex Puberty
female Male Prepubertal Pubertal
age in yearsa -0.29** -0.31* -0.41** -0.15 -0.07 
BMI sDsa 0.55 *** 0.49*** 0.55*** 0.52*** 0.51*** 
fasting insulin -0.14 -0.22 -0.15 0.02 0.09
hOMa-Ir -0.14 -0.21 -0.14 -0.03 0.12 
auC insulin 0.07 -0.06 0.13 0.13 0.22
Oestradiol sDsa 0.14 0.13 0.13 - 0.10
testosterone sDs 0.24 0.44* -0.06 - 0.18 
DhEas sDs 0.29** 0.18 0.33* 0.32* 0.28*
shBG sDs -0.17 -0.10 -0.22 -0.24 -0.31*
Table 3. Correlations are expressed as Spearman’s rho (p-value) unless otherwise stated. a Pearson correlate (p-
value). Correlations for oestradiol SDS and testosterone SDS are calculated on age group ≥ 9 years.  Abbrevia-
tions:  SDS, standard deviation score; BA, bone age; BMI, body mass index; HOMA-IR, homeostatic model as-
sessment for insulin-resistance; AUC, area under the curve; DHEAS, dehydroepiandrosterone sulphate; SHBG, sex 
hormone binding globulin. *p < 0.05; **p <0.01; *** p<0.001. 
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regression analysis for Ba sDs
The results of backward regression analysis are summarized in table 4. In the total co-
hort, backward regression analysis resulted in a model including sex, DHEAS SDS and 
age, explaining 27% of the total variance in BA SDS (overall fit of the regression model 
F=10.55, p<0.001). In the female subgroup we found a model explaining 21% of the vari-
table 4. Backward regression analysis of bone age SDS
Coefficiënt CI 95% r2 p-value
total cohort 
(n=88)
Constant 2.17 1.39/2.96 <0.001
Sex male 0.62 0.18/1.06 0.006
DHEAS SDS 0.27 0.09/0.44 <0.001
Age -0.13 -0.20/-0.06 0.036
Model 0.27 <0.001
female (n=52) Constant 2.68 1.25/4.11 0.001
DHEAS SDS 0.34 0.01/0.66 0.042
SHBG SDS 0.29 -0.04/0.62 0.086
Age -0.14 -0.26/-0.02 0.024
Model 0.21 0.030
Male (n=46) Constant 2.81 1.80/3.81 <0.001
DHEAS SDS 0.31 0.09/0.52 0.006




Constant 2.26 1.17/4.02 0.001
Sex male 0.98 0.30/1.67 0.006
SHBG SDS -0.41 -0.76/-0.09 0.013




Constant 0.70 0.32/1.08 0.001
DHEAS SDS 0.43 0.01/0.85 0.046
Model 0.11 0.046
Table 4. Backward linear regression analysis of bone age SDS. Variables included in all model: age, fasting in-
sulin, HOMA-IR, AUC-insulin, DHEAS SDS, SHBG SDS. In the total cohort and pubertal subgroups, sex was added 
as an independent variable. In the pubertal subgroup only, oestradiol SDS and testosterone SDS were added as 
independent variables. Abbreviations: HOMA-IR, homeostatic model assessment of insulin-resistance; SHBG, sex 
hormone binding globulin; DHEAS, Dihydroepiandrosterone sulphate; SDS, standard deviation score.
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ance in BA SDS including DHEAS SDS, SHBG SDS and age (F=3.33, p=0.030). In contrast, 
in males the model did not include SHBG SDS,  but only contained DHEAS SDS and age 
(F=9.50, p<0.001), explaining 30% of the variance. For the subgroups split on puberty, 
regression analysis showed a model explaining 31% of variance in BA SDS, including sex, 
SHBG SDS and age in prepubertal subjects (F=4.88, p=0.006) and a model explaining 
11% of variance only including DHEAS SDS (F=4.27, p=0.046)  in pubertal subjects. 
DIsCussIOn
The results of this study show that the mechanisms driving BA advancement in obese 
children are complex. In multiple regression analysis we have shown that DHEAS levels 
positively associate with BA SDS and SHBG levels negatively. Results are variable, how-
ever, across subgroups according to sex and pubertal status. Furthermore, we were able 
to explain only a limited percentage of the variance in BA SDS (with a maximum of 31% 
in prepubertal children), indicating that some factors driving bone age advancement 
were not included in this analysis. 
As expected, in this cohort of obese children, mean height SDS was above average 
for the population, and BA was advanced compared to chronological age (CA). Further-
more, BA SDS and BMI SDS were strongly correlated. This is in line with studies reporting 
advanced linear growth and skeletal maturation in children with excess weight (2-4, 21). 
In addition, we have confirmed previous studies (3, 7, 22) showing that obese children 
have high DHEAS levels compared to a reference population. Our observation that 
DHEAS SDS is associated with BA SDS, especially in pubertal children, independent of 
various confounders, is in accordance with the results of a study by Sopher et al., which 
showed that, in a group of obese children, the highest tertile of the ratio between BA 
and CA was associated with high DHEAS levels (6). These authors posed that high DHEAS 
levels indicate high levels of androgens, leading to increased levels of E2 by peripheral 
conversion, which in turn leads to advanced bone maturation. The absence of an as-
sociation between E2 and BA SDS in our cohort might be caused by the fact that our E2 
assay lacks sensitivity in the lower ranges. Consistent with this explanation is a study by 
Klein et al. showing that E2 levels correlated with bone age in obese and lean children 
when using a more sensitive assay (5). Alternatively, it has been suggested that the 
production of E2 takes place at tissue level (6), so that no rise in circulating E2 levels can 
be detected, thereby explaining the lack of association between E2 and BA SDS in our 
cohort.  Furthermore, our findings are in line with the work of DeSalvo et al. who showed 
that, in a cohort of children with premature adrenarche, the subgroup of children with 
BA advancement > 2 years had higher BMI and higher DHEAS levels than the subgroup 
of children with BA advancement < 1 year. This might suggest an overlap between the 
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pathophysiological mechanisms leading to BA advancement in patients with premature 
adrenarche and patients with obesity (23). 
Although the pathophysiological mechanism remains uncertain, the results of our 
study show an independent association between DHEAS SDS and BA SDS in the total 
cohort as well as in males, females and pubertal children, indicating a central role for 
DHEAS in the BA advancement found in obese children. The scientific implications of the 
results of our study are that insulin is an unlikely cause of bone advancement in obese 
children, while DHEAS secretion can now be viewed as at least one of the intermediary 
factors. A possible clinical implication of our findings could be that it would be useful 
to measure DHEAS in obese children with substantial bone age advancement and/or 
increased statural growth. If available, it would also be useful to measure serum oestra-
diol with an ultrasensitive assay. In case of high concentrations, these could be accepted 
as causes of the clinical phenotype, so that the clinician can consider abstaining from 
further diagnostic workup of the patient.
Our finding of decreased plasma SHBG levels in obese children compared to reference 
intervals, based on lean children, is in accordance with previous reports (3, 7, 23) and has 
been reported to be caused by hyperinsulinemia, related to insulin resistance and low 
grade inflammation (24). Using sensitive E2 assays, it was also shown that obese adoles-
cents have increased E2 levels, combined with decreased SHBG levels, possibly resulting 
in high levels of free E2 (23), which in turn might lead to increased bone maturation (24). 
In addition to the generally decreased SHBG in obese children, we found a negative 
association in the regression analysis of SHBG SDS with BA SDS in prepubertal children. 
Decreased SHBG is associated with the increase of andrenal androgens during puberty 
(25), which in there turn, can stimulate bone maturation by locally increasing oestrogen 
levels via expression of aromatase (26). In contrast, a trend toward a positive association 
between SHBG SDS and BA SDS was found in regression analysis in the female subgroup, 
possibly reflecting increased gonadal oestrogen production during puberty, stimulating 
SHBG in girls. This association, however, did not reach significance (p=0.086), possibly 
because it is obscured by lack of assay sensitivity or the combination of the results of 
two oestrogen immunoassays.
It is of interest that we did not find an association between any of the insulin pa-
rameters with bone age advancement, neither in correlation analyses, nor in regression 
analyses. In the literature, contradictory results on the association between hyperinsu-
linemia and advanced bone age have been reported. No association between insulin 
resistance and the ratio between BA and CA was found in prepubertal children in a study 
by Sopher et al. (6) whereas Klein et al. found an association between insulin levels and 
the top tertile of this ratio in a cohort aged 3-18 years (5). Furthermore, Pinhas-Hamiel et 
al. showed that overweight children aged 4-13 years with a fasting insulin > 30 mU/l had 
a 6.8 fold increased risk of falling into the top tertile of the ratio between BA and CA, 
Determinants of advanced bone age in childhood obesity 89
5
independent of degree of obesity (11).  Lee et al. investigated the relation between in-
sulin resistance and bone age in prepubertal obese children and found an independent, 
positive correlation between HOMA-IR and the difference between BA and CA using 
multiple regression analysis (10).  None of these three studies, however, corrected for 
the possible confounding effects of androgens and oestrogens, which might bias these 
results, and the outcome parameter of bone advance was not adjusted for age and sex. 
Furthermore, there was considerable variability in ethnicity between studies, which 
might in part explain the differences in outcome. In addition, the positive association 
between insulin secretion and age could lead to bias too. Another possible explanation 
for the lack of association between bone age SDS and insulin parameters in this cohort 
might be that a large number of the subjects in this cohort is already insulin resistant. 
Possibly the effects of insulin on bone age are more pronounced in children in the early 
stages of developing insulin resistance.
The finding of independent effects of sex in the multiple regression analysis is remark-
able. It suggests that male and female subjects are differentially affected by increased 
BMI in their advanced bone maturation. This is in agreement with the findings of Crocker 
et al. who have recently shown that pubertal development is differentially affected in 
obese male and female subjects. They showed that, in female subjects, progressive 
Tanner staging correlated with advanced BA, while in boys BA advancement was inde-
pendent of testicular development. Furthermore, insulin resistance correlated positively 
with breast development in girls while it was negatively correlated with testicular size in 
boys (27). This underlines the sexual dimorphism in the way obesity affects maturation. 
As shown in our regression models, the maximum percentage of variance explained 
by a model was 31%, suggesting that factors not included in this study might contribute 
to BA advancement. It has been suggested that leptin (28) and IGF-1 (8) might contrib-
ute to bone age advancement in obesity, although recent work by Sopher et al. showed 
no association between these parameters and BA advancement (6). Future studies in 
larger cohorts should include these parameters to clarify the role these factors play in 
this matter.
A major strength of our study is the use of an automated method for BA assessment, 
which results in a reduced inter-subject, and an absent inter-observer variance (29). The 
use of BoneXpert also enabled the calculation of a reliable BA SDS from a representative 
population reference.  Furthermore, where possible, we used age and sex specific SDS 
to investigate the relationship between hormone levels and BA SDS, thereby correct-
ing for variance in these hormones caused by age and sex. Furthermore, we corrected 
for multiple confounders using regression analysis, which makes a causal relationship 
between the observed factors associated with advanced BA more plausible. 
A limitation of our study is the fact that BoneXpert only supports the BA assessment of 
boys between 2.5 – 17 years and girls between 2.0 – 15 years (15, 16). However, older ad-
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olescents have usually reached near adult height by this age, and we pose that therefore 
they are a clinically less relevant study group.  Secondly, BoneXpert contains reference 
data for standard deviation scores of Caucasian, Asian, Hispanic, or Afro-Americans (16) 
but not from children of Turkish or Moroccan background. Therefore, we used Caucasian 
references as the standard for all children. The majority of the cohort, however, is Cau-
casian. A third limitation is that the assays for oestradiol has a limited sensitivity, which 
might obscure its association with BA SDS in prepubertal children. Finally, due to the 
large number of potential confounders included in the regression models, our sample 
size was too small to investigate sex effects separately in the prepubertal and pubertal 
age group. In addition, the small sample size in some subgroups (e.g. prepubertal), may 
have led to false negative results in the multiple regression analysis. Future research 
should therefore include larger cohorts, allowing for adjusting for multiple confounders 
in the regression analysis. Furthermore, longitudinal designs could help to gain addi-
tional insights into the mechanisms driving accelerated bone maturation in obesity. In 
addition, future studies would benefit from age and sex specific SDS for Adione and 
insulin, and should include leptin and IGF-1. 
In conclusion, using multiple regression analysis, we have shown that increased DHEAS 
levels, reflecting adrenal androgen production, play a central role in BA advancement in 
obese children and adolescents and that decreased SHBG levels may further contribute 
to this phenomenon, though this finding needs further investigation.
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Supplementary fi gure 1. A: scatterplot of SHBG SDS versus age. B: SHBG (nmol/l) versus age in males plotted on 
the age reference range. C: SHBG (nmol/l) versus age in females, plotted on the age reference range. Abbrevia-
tions: SDS, standard deviation score; SHBG, sex hormone binging globulin. The coloured lines represent refer-
ences values of normal weight children from Elmlinger et. al. (19).
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Supplementary fi gure 2. A: scatterplot of DHEAS SDS versus age. B: DHEAS (µmol/l) versus age in males plotted 
on the age reference range. C: DHEAS (µmol/l) versus age in females, plotted on the age reference range. Abbre-
viations: SDS, standard deviation score; DHEAS, dehydroepiandrosterone sulphate. The coloured lines represent 
references values of normal weight children from Elmlinger et. al. [19].
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Supplementary fi gure 3. A: scatterplot of testosterone SDS versus age. B: testesterone (nmol/l) versus age in 
males plotted on mean ± 1SD lines based on a reference population. C: testosterone (nmol/l) versus age in fe-
males plotted on mean ± 1SD lines based on a reference population. Abbreviations: SDS, standard deviation 
score. The coloured lines represent references values of normal weight children from Konforte et. al. [20].
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Supplementary fi gure 4. A: scatterplot of oestradiol SDS versus age. B: oestradiol (pmol/l) versus age in males 
plotted on mean ± 1SD lines based on a reference population . C: oestradiol (pmol/l) versus age in females plot-
ted on mean ± 1SD lines based on a reference population . Abbreviations: SDS, standard deviation score. The 
coloured lines represent references values of normal weight children from Konfronte et. al. [20].
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There is debate on which overweight and obese children should be screened for the 
presence of impaired glucose tolerance (IGT) by oral glucose tolerance testing (OGTT).
Objective 
Identify risk factors predictive of the presence of IGT.
Method 
In a cohort of overweight children, who underwent OGTT, we determined the asso-
ciation of anthropometric and laboratory parameters with IGT and whether combining 
parameters improved the sensitivity of screening for IGT. 
results 
Out of 145 patients, IGT was present in 11, of whom 2 had impaired fasting glucose 
(IFG). Elevated blood pressure (p=0.025) and elevated liver enzymes (p=0.003) were 
associated with IGT, whereas IFG was not (p=0.067), screening patients with either one 
of these parameters predicted IGT with a high sensitivity of 1.00, and a number needed 
to screen of 5.7. 
Conclusion 
Screening all patients with either IFG, presence of elevated blood pressure and elevated 
liver enzymes, significantly increases predictability of IGT compared to using IFG alone. 
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IntrODuCtIOn
The global prevalence of childhood obesity has risen dramatically in the last decades(1-3). 
In the Netherlands, the number of children classified as overweight has increased two- 
to three -fold, whereas the prevalence of obesity has even increased four- to six-fold in 
the last 30 years(4). This rise has been shown to be closely correlated with a rise in type 
2 diabetes mellitus and metabolic syndrome(5-7). Identifying which children are at high 
risk for developing type 2 diabetes is crucial for determining the individual treatment 
strategy. The optimal strategy to screen for type 2 diabetes and prediabetes, however, 
remains the subject of debate among clinicians and healthcare workers.  
Type 2 diabetes is preceded by a period of insulin resistance, ultimately resulting in 
the prediabetic phenotypes impaired fasting glucose (IFG), defined as a fasting glucose 
concentration ≥ 5.6 mmol/l(8) and impaired glucose tolerance (IGT), defined as a 2-hour 
glucose concentration ≥ 7.8 mmol/l(8) during oral glucose tolerance testing (OGTT)
(9-11). Finding children with IGT is essential, since a considerable number of them 
progress into type 2 diabetes, especially when BMI increases over time(11,12). This war-
rants a more intensive treatment and follow up for these patients. The Dutch guideline, 
however, suggests to perform OGTT in patients with IFG(13), while recent research has 
shown that IFG correlates poorly with IGT(6, 9, 14-19). 
The major reason for using IFG in the current guideline is that it is easier and more 
reproducible than IGT in children and adolescents(20). On the other hand, discussion is 
ongoing on the clinical value of fasting glucose in comparison to OGTT, because fasting 
plasma glucose measurement misses most of the cases with glucose dysregulation. In 
addition, children with discordant results on OGTT are still at high risk for developing 
type 2 diabetes(20). Furthermore, IGT is more predictive than IFG of future progression 
to type 2 diabetes(11). This underlines the importance of finding children with IGT. 
Consequently, various parameters have been evaluated for their predictive value of 
developing IGT. A number of studies have indicated that the homeostatic model as-
sessment of insulin resistance (HOMA-IR), the quantitative insulin sensitivity check index 
(QUICKI) and other surrogate measures of insulin resistance and sensitivity correlate 
with IGT(14,17,21,22) and that HOMA-IR is a more useful parameter than IFG(19). Lipid 
levels, that have also been shown to correlate with IGT(14,17), demonstrate a good 
sensitivity when used in a selective obese population(17) and are predictors of long 
term development of type 2 diabetes(23). Furthermore, elevated blood pressure in 
childhood has been shown to be associated with IGT(14) and development of type 2 
diabetes in adulthood(23). Additionally HbA1c has been suggested to be predictive of 
IGT (24,25), but results are contradictory(24). Other parameters possibly predictive of 
IGT are elevated liver enzymes (e.g. AST and ALT), since they signal liver steatosis, which 
is associated with insulin resistance(26). Furthermore, IGT is highly prevalent in children 
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with non-alcoholic fatty liver disease(27), further underlining the possible predictive 
value of liver enzymes.
Although these parameters are promising for providing a better diagnostic approach 
for predicting IGT, these studies either fail to provide cut-off points, are performed in 
a selective population, or lack sufficient sensitivity. This makes it hard to implement 
this body of knowledge into everyday practice. The aim of this study is to evaluate the 
sensitivity, specificity, predictive values and numbers needed to screen in predicting 
IGT of diagnostic parameters using widely accepted cut-offs in a group of overweight 
and obese children, in whom OGTT was performed as a standard of care. Furthermore, 
we hypothesise that a combination of parameters could improve the sensitivity of the 
strategy for finding individuals at high risk of IGT.
PatIEnts anD MEthODs
Patient characteristics
All patients visiting the obesity clinic of the Willem-Alexander Children’s Hospital be-
tween January 2012 and July 2015 were analysed. Patients with obesity as defined by 
Cole(28) were all tested by OGTT as a standard of care. Patients who were classified as 
overweight were tested with OGTT if they had an increased risk of type 2 diabetes. This 
was defined based on the risk criteria as defined in the American Diabetes Association 
guideline (e.g having a family history of type 2 diabetes, acanthosis nigricans at first 
presentation, ethnicity other than Caucasian)(8). The medical ethics committee of the 
Leiden University Medical Centre approved the study. This study was conducted in ac-
cordance with the terms of the declaration of Helsinki.
anthropometric measurements and definitions
A medical history was obtained, including information on ethnicity and family history of 
type 2 diabetes, at the first obesity clinic visit. Puberty stage was assessed according to 
Tanner(29). Height was measured to the nearest 0.1 cm with a stadiometer, and weight 
to the nearest 0.1 kg using a calibrated scale, with clothing and footwear removed 
except for underwear. Overweight and obesity class I where defined as described by 
Cole(28) and obesity class II and III and waist circumference SD-scores were classified 
using the data of the fifth Dutch national growth study(30). These BMI-classes are deter-
mined using age and sex specific curves, and correspond with an adult BMI of ≥ 25-29.9 
kg/m2 for overweight, ≥ 30-34.9 kg/m2 for obesity class I, ≥ 35-39.9 kg/m2 for obesity 
class II and ≥ 40 kg/m2for class III. Blood pressure (BP) was measured in sitting position 
using an electronic sphygmomanometer (Dinamap Pro 300 V2, GE Medical Systems, 
Tampa, Florida, USA). The lowest BP value out of three consecutive measurements was 
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recorded. Elevated blood pressure was defined as diastolic or systolic blood pressure 
values exceeding the 95th percentile for age, sex and height using the cut-off values 
described by the National High Blood Pressure Education Program Working Group(31).  
OGtt procedure
OGTT was performed after an overnight fast of at least 10 hours. Glucose dose was 1.75 
g/kg with a maximum of 75 g. Blood samples were taken from an intravenous catheter at 
t=0, 30, 60 and 120 minutes to determine glucose concentrations. At t=0 an extra blood 
sample was taken for the analysis of lipids, insulin and liver enzymes.
Laboratory measurements and definitions
All laboratory analyses were conducted by the hospital laboratory of the Leiden University 
Medical Centre (LUMC Leiden, The Netherlands). Plasma glucose levels were determined 
using hexokinase method using Roche Modular Analytics P800 (Roche). Plasma insulin 
levels were measured with the use of a sandwich immunoassay using Immulite 2000 
Xpi (Siemens Healthcare diagnostics). Impaired fasting glucose and impaired glucose 
tolerance were defined using the ADA criteria, i.e. IFG is fasting glucose ≥ 5.6 mmol/L 
and < 7.0 mmol/L and IGT is 2-hour glucose concentration ≥ 7.8 mmol/L and < 11.1 
mmol/L during OGTT(8). Type 2 diabetes was defined as fasting plasma glucose ≥ 7.0 
mmol/L or 2-hour plasma glucose ≥ 11.1 mmol/L. Glucose abnormalities were defined 
as having either IFG, IGT or type 2 diabetes. HOMA-IR was calculated by the following 
formula: glucose (mmol/L)* insulin (mU/L) / 22.5(32). We chose a cut-off of HOMA-IR ≥ 
3,4 because this cut-off improved the prediction of IGT compared to using IFG in previ-
ous research(19, 33, 34). HbA1c was determined by ion exchange chromatography using 
Ultra2 HbA1c affinity analyser (Trinity Biotech). HDL-cholesterol, total cholesterol and 
triglycerides were measured using enzymatic methods (Roche Modular Analytics P800, 
Roche) and LDL-cholesterol was calculated using Friedewald’s formula (LDL-cholesterol 
= total cholesterol – HDL-cholesterol – 0.456 * triglycerides)(35). Elevated total choles-
terol, LDL-cholesterol and triglycerides were defined as values exceeding the p95 for age 
and sex. For HDL-cholesterol a value below p5 for age and sex was considered abnor-
mal(36). Dyslipidaemia was defined as having any abnormality in the lipid profile. ALT 
and AST were measured using the standard methods of the International Federation of 
Clinical Chemistry and Laboratory Medicine (IFCC)(37) and gamma GT was analysed by 
the calorimetric enzymatic method (Roche Modular Analytics P800). Cut-off points were 
sex specific(37) as provided by the manufacturer. The variable ‘elevated liver enzymes’ 
was defined as elevated levels of either ALT, AST or gamma GT above the reference range. 
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statistical analysis
All data were analysed using SPSS 20.0.0. Differences between normal glucose tolerant 
and impaired glucose tolerant individuals were explored using a Mann-Whitney U test, 
for continuous data. Fischer Exact test was used for nominal and ordinal data, unless oth-
erwise stated. Parameters significantly associated with presence of IGT were compared 
with IFG considering sensitivity, specificity, number needed to screen in predicting IGT 
and percentage of cases of IGT missed. Furthermore, we evaluated the sensitivity, speci-
ficity, number needed to screen in predicting IGT and percentage of cases of IGT missed 
when taking the number of abnormal screening parameters in to account. 
rEsuLts
Characteristics of normal- and impaired glucose tolerant patients
A total of 181 patients visited the Willem-Alexander Children’s Hospital obesity clinic 
between January 2012 and July 2015. In 24 patients OGTT was not performed because 
they were overweight and were classified as ‘no increased risk of type 2 diabetes’. In 8 
patients OGTT was not performed for other reasons (e.g. problems with catheter place-
ment, OGTT recently performed in another hospital). Four patients did have an OGTT, 
but were excluded from the analysis (one because of a missing 2-hour glucose value, 
one was diagnosed with mature-onset diabetes of the young during follow-up, one 
was suspected of having an overgrowth syndrome and one was excluded because of 
unreliable outcome of OGTT due to vomiting after glucose ingestion). Therefore, a total 
of 145 patients were included in this study. 89 were of Dutch descent, 9 had a western 
background other than Dutch, 17 were of Moroccan origin, 5 were of Turkish origin and 
27 had another non-western background.   The baseline characteristics of the cohort 
and the comparison between NGT and IGT patients are shown in table 1. In total, 15 out 
of 145 subjects were diagnosed with glucose abnormalities. Of these 15 subjects, 6 were 
diagnosed with IFG, of whom two were also diagnosed with IGT. Based on the OGTT, 
11 out of 15 subjects were diagnosed with IGT. None of the subjects were diagnosed 
with type 2 diabetes. IGT subjects had significantly higher numbers of elevated blood 
pressure (p=0.035) and elevated liver enzymes (p=0.003). Furthermore, subjects with 
IGT had higher triglyceride levels (p=0.014) and lower HDL-cholesterol levels (p=0.030). 
When considering the number of subjects exceeding the reference range, however, 
there was no between group difference for these parameters. All but 1 IGT subjects were 
pubertal. When considering pubertal subjects only, elevated blood pressure (p=0.028) 
and elevated liver enzymes (p=0.003) were still the only parameters significantly higher 
in IGT subjects. 
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table 1 Characteristics of the cohort and comparison of NGT and IGT subjects.
total n=145 nGt n=134 IGt n=11 p-value
Sex female (%) 77 (53) 72 (54) 5 (46) p>0.10
Age 11.6 (8.1-14.4) 11.5 (8.0-14.2) 14.3 (11.9-15.3) 0.048
Ethnicity Caucasian (%) 96 (66) 87 (65) 9 (82) p>0.10
BMI SDS 3.3 (2.9-3.8) 3.3 (2.9-3.8) 3.8 (3.2-4.3) p>0.10
Waist circumference SDS 3.1 (2.8-3.5) 3.1 (2.8-3.4) 2.9 (2.9-3.9) p>0.10
Acanthosis nigricans (%) 58 (41) 52 (40) 6 (60) p>0.10

















Pubertal subjects (%) 85 (63) 76 (61) 10 (91) 0.097
OGTT Glucose mmol/l t=0 4.4 (4.2-4.8) 4.4 (4.2-4.8) 4.6 (4.2-5.3) p>0.10
OGTT Glucose mmol/l t=30 7.4 (6.3-8.3) 7.3 (6.3-8.3) 7.9 (7.3-8.4) p>0.10
OGTT Glucose mmol/l t=60 6.2 (5.2-7.5) 6.1 (5.2-7.2) 9.3 (7.8-10.7) <0.001
OGTT Glucose mmol/l t=120 5.8 (5.2-6.6) 5.7 (5.1-6.4) 8.5 (8.1-9.6) <0.001
IFG (%) 6 (4) 4 (3) 2 (18) 0.067
IGT (%) 11 (8) na na na
Type 2 diabetes (%) 0 (0) na na na
HbA1c mmol/mol 33 (32-35) 33 (32-35) 35 (32-36) p>0.10
HbA1c > 40 mmol/mol (%) 1 (1) 1 (1) 0 (0.0) p>0.10
HOMA-IR 2.3 (1.3-3.8) 2.1 (1.3-3.8) 2.9 (1.3-7.0) p>0.10
HOMA-IR > 3.4 (%) 45 (32) 41 (31) 4 (40.0) p>0.10
Systolic BP mmHg 115 (109-125) 115 (108-124) 131 (118-134) 0.007
Diastolic BP mmHg 69 (65-75) 67 (64-73) 72 (69-78) 0.025
Elevated BP (%) 88 (69) 33 (28) 7 (64) 0.035
AST U/L 26 (22-31) 25 (22-31) 34 (28-43) 0.007
Elevated AST (%) 27 (21) 21 (18) 6 (60) 0.006
ALT U/L 21 (15-27) 20 (15-26) 34 (26-65) 0.002
Elevated ALT (%) 15 (11) 11 (9) 4 (40) 0.015
Gamma GT U/L 16 (12-22) 15 (11-20) 24 (21-34) 0.001
Elevated Gamma GT (%) 4 (3) 3 (2) 1 (9) p>0.10
Elevated liver enzymes (%) 31(23) 24 (19) 7 (64) 0.003
Triglycerides mmol/l 0.9 (0.7-1.2) 0.9 (0.7-1.1) 1.2 (1.0-1.8) 0.014
Triglycerides > p95 (%) 29 (21) 25 (20) 4 (36) p>0.10
Cholesterol mmol/l 4.0 (3.6-4.6) 4.0 (3.6-4.5) 4.2 (3.5-5.6) p>0.10
Cholesterol > p95 (%) 13 (9) 10 (8) 3 (27) 0.070
LDL-cholesterol mmol/l 2.4 (2.2-2.8) 2.4 (2.0-2.8) 2.6 (2.2-3.8) p>0.10
LDL-cholesterol > p95 (%) 13 (10) 10 (8) 3 (27) 0.070
HDL-cholesterol mmol/l 1.2 (1.0-1.3) 1.2 (1.0-1.3) 1.0 (0.9-1.2) 0.030
HDL-cholesterol < p5 (%) 19 (13) 17 (13) 2 (18) p>0.10
Dyslipidemia (%) 48 (35) 42 (33) 6 (55) p>0.10
Table 1. Percentages are valid percentages. Data are expressed as median with IQR unless otherwise stated. 
Abbreviations: BP: Blood Pressure, NGT: Normal Glucose Tolerance, IGT: Impaired Glucose Tolerance, BMI: Body 
Mass Index, SE: Standard Error, SDS: Standard Deviation Score, IFG: Impaired Fasting Glucose, IGT: Impaired Glu-
cose Tolerance, OGTT: Oral Glucose Tolerance Test,  na: not applicable. 
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relationship of predefined risk factors with IGt
In Table 2 the associations with IGT are compared for IFG, elevated blood pressure 
and elevated liver enzymes with regard to their sensitivity, specificity, number needed 
to screen and percentage of patients with IGT missed, when using this parameter to 
determine whether OGTT is necessary. The sensitivity of IFG was 0.18. The maximum 
sensitivity of a single parameter was 0.64 for elevated blood pressure and elevated 
liver enzymes. Analysing pubertal subjects only showed similar results for IFG (sensitiv-
ity 0.20, specificity 0.96), elevated blood pressure (sensitivity 0.70, specificity 0.66) and 
elevated liver enzymes (sensitivity 0.60, specificity 0.80).
analysis of the number of abnormal diagnostic parameters and the presence of 
IGt
All patients with IGT (n=11) had one or more abnormalities in the parameters IFG, 
elevated blood pressure and elevated liver enzymes. If all subjects with one or more 
abnormal diagnostic parameters were to be examined by OGTT this would result in a 
sensitivity of 1.00 (95% CI 0.74-1.00), a specificity of 0.56 (0.49-0.65), a number needed 
to screen of 5.7 and no cases of IGT missed (table 3). Only analysing those subjects with 
elevated blood pressure or elevated liver enzymes would result in a sensitivity of 0.91 
(0.62-0.98) and a specificity of 0.64 (0.56-0.72) and a similar number needed to screen 
(5.8). 











IFG (%) 4 (3) 2 (18) 0.18 (0.05-0.48) 0.97 (0.93-0.99) 3.0 9 (82)
Elevated BP (%) 33 (28) 7 (64) 0.64 (0.35-0.85) 0.75 (0.67-0.82) 5.7 4 (36)
Elevated liver enzymes (%) 24 (19) 7 (64) 0.64 (0.35-0.85) 0.82 (0.75-0.88) 4.4 4 (36)
Table 2 Percentages shown are valid percentages. Abbreviations: NGT: Normal Glucose Tolerance, IGT: Impaired 
Glucose Tolerance, IFG: impaired fasting glucose, NNS: number needed to screen, IGT missed: number of cases 
missed if this parameter was used to assess the necessity to perform OGTT, ns: not significant.
table 3 Predictability of IGT by combining significant risk factors












0 82 0 <0.001 Na na 13.2 0 (0)





Table 3 Abbreviations: NGT: Normal Glucose Tolerance, IGT: Impaired Glucose Tolerance, NNS: number need-
ed to screen, IGT missed: number of cases missed if this parameter was used to assess the necessity to perform 
OGTT,  na: not applicable. bnumber of abnormal screening parameters in IFG, elevated blood pressure and liver 
enzymes.
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DIsCussIOn
The results of the present study show that combining diagnostic parameters, available in 
every day practice, can significantly improve the screening strategy to identify subjects 
at high risk of IGT among obese children. Additionally, this study extends the evidence 
stating that IFG correlates poorly with IGT and is not a parameter with sufficient sensitiv-
ity to predict IGT. The percentage of cases of IGT missed and the number needed to 
screen using IFG as a parameter to assess the necessity to perform an OGTT, are high. 
Remarkably, our data show that elevated liver enzymes and elevated blood pressure 
were more useful in predicting IGT than IFG, considering sensitivity and number needed 
to screen (Table 3). 
Combining the parameters IFG, elevated blood pressure and elevated liver enzymes 
and using a cut-off of 1 or more abnormal parameters, increased the sensitivity of find-
ing patients with IGT to 1.00 with a number needed to screen of 5.7 (Table 3). Identify-
ing patients with IGT is of the utmost importance, since they are at increased risk of 
developing type 2 diabetes (11, 12). Therefore, obesity treatment of patients with IGT, 
is more intensive and has a more frequent follow-up, as recommended in the current 
guideline(13). A major strength of the current study is that the results of this study are 
applicable to the general population of children with obesity, since all obese patients 
underwent OGTT without selection. 
Implementing our model in practice could have various implications for healthcare. 
A major advantage of this approach is that it only uses parameters that are available in 
everyday practice. Furthermore, the number needed to screen is relatively low, com-
bined with a high sensitivity, which makes it an attractive screening strategy. Although 
one might pose that implementing this strategy would strain healthcare budgets and 
manpower by an increasing number of OGTT’s (e.g. a patient has to stay in the hospital 
or clinic for 2 hours), only performing OGTT’s in patients with IFG has been proven insuf-
ficient by a vast body of previous evidence(6, 9, 14, 15, 17). In our population, applying 
the strategy of only testing subjects with IFG, elevated blood pressure and elevated 
liver enzymes would mean that approximately one third of our cohort would undergo 
an OGTT. This number would be substantially lower if only pubertal subjects would be 
screened, or only those with elevated blood pressure and/or elevated liver enzymes. In 
this cohort, however, applying either one of these strategies would result in cases of IGT 
missed, which is undesirable. It has to be noted, though, that only screening patients 
with elevated blood pressure and/or elevated liver enzymes would be interesting for 
clinical practice, since this would waive the necessity to perform fasting screening. 
Therefore, further research on these parameters, possibly combined with other non-
fasting parameters, could have important implications for clinical practice. In summary 
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we provide a model for selecting patients at high risk of having IGT, with good sensitivity 
and an acceptable number needed to screen.
The finding that elevated liver enzymes predict IGT is of particular interest (Table 1). It is 
in line with research in adults, showing a correlation between elevated AST and ALT and 
prediabetes(38). It is in contrast, though, with a recent report concerning a population of 
Thai adolescents(18). However, this study was performed in a group of adolescents with 
obesity at high risk for co-morbidity, whereas we did not select the high-risk patients in 
our group defined as ‘obese’. Elevated liver enzymes probably signal hepatic steatosis, a 
common complication in childhood obesity(9, 26). Recently it was shown that children 
with hepatic steatosis show a high prevalence of IGT(27). Furthermore, hepatic steatosis 
is associated with insulin resistance(9, 26) and metabolic syndrome(39), both of which 
are also associated with IGT, showing a possible shared causative origin. Our study adds 
to the literature that the presence of elevated liver enzymes is a highly predictive of IGT, 
especially when combined with IFG. 
Another finding of interest is that there was only one subject with abnormal HbA1c 
levels in our cohort (Table 1). This might be the reason that we could not find a correla-
tion between HbA1c levels and presence of IGT. In literature on this subject, prevalence 
is usually higher(25, 26, 40). These studies differed from our cohort in respect of ethnic-
ity, since they were largely Korean(24, 40) and Hispanic(25). Furthermore, although it 
was previously shown in adults that the association of HbA1c with IGT is only mod-
est, it is a highly sensitive parameter for detecting the presence of type 2 diabetes in 
children(41), correlates well with abnormal glucose indices as measured by continuous 
glucose monitoring(42) and has the advantage of easy measurement in daily practice. 
However, both HbA1c and OGTT are of separate added value as they identify different 
patient populations with likely different underlying insulin metabolism abnormalities, 
and are not sequential in their appearance(41). 
There are limitations to consider in respect to this study. Although there was no selec-
tion of the patients classified as obese, we only included high-risk overweight patients 
which might have caused selection bias for the small overweight group. However, only 
24 patients were excluded on a total of 181 based on the fact that they were at low-risk 
of type 2 diabetes and in the overweight class. Furthermore, some screening param-
eters were not included in this study that deserve further research. Thyroid-stimulating 
hormone, for example, has been shown to be associated with glucose metabolism 
abnormalities(43).  
Future research is needed to confirm whether our findings can be replicated in patient 
groups with a different profile on age, country or ethnicity. If our findings are confirmed, 
this model is suitable for implementation in daily practice and could have consequences 
for current guidelines on screening for co-morbidity obese children is. 
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In conclusion, this paper provides a new method of screening for IGT, with high 
sensitivity and a low number needed to screen compared to using IFG alone. Our data 
show that in patients with 1 or more abnormal diagnostic parameters, i.e. IFG, elevated 
blood pressure and elevated liver enzymes, there is a high risk of IGT and therefore these 
patients should be investigated by OGTT. This model is easy to use, simple and feasible 
for implementation in current clinical practice.
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rEfErEnCEs
 1. Gupta N, Shah P, Nayyar S, Misra A. Childhood obesity and the metabolic syndrome in developing 
countries. Indian JPediatr. 2013;80:S28-S37.
 2. Lobstein T, Frelut ML. Prevalence of overweight among children in Europe. ObesRev. 2003;4:195-
200.
 3. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of obesity and trends in body mass index 
among US children and adolescents, 1999-2010. JAMA. 2012;307:483-90.
 4. Schonbeck Y, Talma H, van Dommelen P, Bakker B, Buitendijk SE, HiraSing RA, et al. Increase in 
prevalence of overweight in Dutch children and adolescents: a comparison of nationwide growth 
studies in 1980, 1997 and 2009. PLoSOne. 2011;6:e27608.
 5. Rotteveel J, Belksma EJ, Renders CM, Hirasing RA, Delemarre-Van de Waal HA. Type 2 diabetes in 
children in the Netherlands: the need for diagnostic protocols. EurJEndocrinol. 2007;157:175-80.
 6. Sinha R, Fisch G, Teague B, Tamborlane WV, Banyas B, Allen K, et al. Prevalence of impaired glucose 
tolerance among children and adolescents with marked obesity. NEnglJMed. 2002;346:802-10.
 7. Tirosh A, Shai I, Afek A, Dubnov-Raz G, Ayalon N, Gordon B, et al. Adolescent BMI trajectory and 
risk of diabetes versus coronary disease. NEnglJMed. 2011;364:1315-25.
 8. Standards of medical care in diabetes--2012. Diabetes Care. 2012;35:S11-S63.
 9. Cali AM, Bonadonna RC, Trombetta M, Weiss R, Caprio S. Metabolic abnormalities underlying the 
different prediabetic phenotypes in obese adolescents. JClinEndocrinolMetab. 2008;93:1767-73.
 10. Weiss R, Dufour S, Taksali SE, Tamborlane WV, Petersen KF, Bonadonna RC, et al. Prediabetes in 
obese youth: a syndrome of impaired glucose tolerance, severe insulin resistance, and altered 
myocellular and abdominal fat partitioning. Lancet. 2003;362:951-7.
 11. Weiss R, Taksali SE, Tamborlane WV, Burgert TS, Savoye M, Caprio S. Predictors of changes in 
glucose tolerance status in obese youth. Diabetes Care. 2005;28:902-9.
 12. Franks PW, Hanson RL, Knowler WC, Moffett C, Enos G, Infante AM, et al. Childhood predictors of 
young-onset type 2 diabetes. Diabetes. 2007;56:2964-72.
 13. 'Guideline - Evaluation and treatment of obesity in adults and children'. CBO; 2010.
 14. Cambuli VM, Incani M, Pilia S, Congiu T, Cavallo MG, Cossu E, et al. Oral glucose tolerance test in 
Italian overweight/obese children and adolescents results in a very high prevalence of impaired 
fasting glycaemia, but not of diabetes. Diabetes Metab ResRev. 2009;25:528-34.
 15. Conwell LS, Batch JA. Oral glucose tolerance test in children and adolescents: positives and 
pitfalls. JPaediatrChild Health. 2004;40:620-6.
 16. Kleber M, de Sousa G, Papcke S, Wabitsch M, Reinehr T. Impaired glucose tolerance in obese 
white children and adolescents: three to five year follow-up in untreated patients. ExpClinEndo-
crinolDiabetes. 2011;119:172-6.
 17. Love-Osborne K, Butler N, Gao D, Zeitler P. Elevated fasting triglycerides predict impaired glucose 
tolerance in adolescents at risk for type 2 diabetes. PediatrDiabetes. 2006;7:205-10.
 18. Tirabanchasak S, Siripunthana S, Supornsilchai V, Wacharasindhu S, Sahakitrungruang T. Insulin 
dynamics and biochemical markers for predicting impaired glucose tolerance in obese Thai 
youth. JPediatrEndocrinolMetab. 2015.
High predictability of impaired glucose tolerance by combining cardiometabolic screening parameters in obese children 113
6
 19. van der Aa MP, Fazeli FS, Kromwijk LA, de Boer A, Knibbe CA, van der Vorst MM. How to screen 
obese children at risk for type 2 diabetes mellitus? ClinPediatr. 2014;53:337-42.
 20. Libman IM, Barinas-Mitchell E, Bartucci A, Robertson R, Arslanian S. Reproducibility of the oral 
glucose tolerance test in overweight children. JClinEndocrinolMetab. 2008;93:4231-7.
 21. Maffeis C, Pinelli L, Brambilla P, Banzato C, Valzolgher L, Ulmi D, et al. Fasting plasma glucose 
(FPG) and the risk of impaired glucose tolerance in obese children and adolescents. Obesity. 
2010;18:1437-42.
 22. Velasquez-Mieyer PA, Cowan PA, Neira CP, Tylavsky F. Assessing the risk of impaired glucose 
metabolism in overweight adolescents in a clinical setting. JNutrHealth Aging. 2008;12:750S-7S.
 23. Morrison JA, Glueck CJ, Horn PS, Wang P. Childhood predictors of adult type 2 diabetes at 9- and 
26-year follow-ups. ArchPediatrAdolescMed. 2010;164:53-60.
 24. Lee HS, Park HK, Hwang JS. HbA1c and glucose intolerance in obese children and adolescents. 
DiabetMed. 2012;29:e102-e5.
 25. Tsay J, Pomeranz C, Hassoun A, Zandieh SO, Rutledge J, Vogiatzi MG, et al. Screening markers of 
impaired glucose tolerance in the obese pediatric population. HormResPaediatr. 2010;73:102-7.
 26. D'Adamo E, Impicciatore M, Capanna R, Loredana MM, Masuccio FG, Chiarelli F, et al. Liver steato-
sis in obese prepubertal children: a possible role of insulin resistance. Obesity. 2008;16:677-83.
 27. Schiaffini R, Liccardo D, Alisi A, Benevento D, Cappa M, Cianfarani S, et al. Early Glucose Derange-
ment Detected by Continuous Glucose Monitoring and Progression of Liver Fibrosis in Nonalco-
holic Fatty Liver Disease: An Independent Predictive Factor? HormResPaediatr. 2016;85:29-34.
 28. Cole TJ, Bellizzi MC, Flegal KM, Dietz WH. Establishing a standard definition for child overweight 
and obesity worldwide: international survey. BMJ. 2000;320:1240-3.
 29. Tanner JM. Growth and maturation during adolescence. NutrRev. 1981;39:43-55.
 30. Talma H, Schonbeck Y, Bakker B, HiraSing RA, Buuren Sv. 'Growthcharts 2010: Guide for measuring 
and weighing children and filling out growth charts': TNO Kwaliteit van leven; 2010.
 31. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children 
and adolescents. Pediatrics. 2004;114:555-76.
 32. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model 
assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin 
concentrations in man. Diabetologia. 1985;28:412-9.
 33. Allard P, Delvin EE, Paradis G, Hanley JA, O'Loughlin J, Lavallee C, et al. Distribution of fasting 
plasma insulin, free fatty acids, and glucose concentrations and of homeostasis model assess-
ment of insulin resistance in a representative sample of Quebec children and adolescents. 
ClinChem. 2003;49:644-9.
 34. D'Annunzio G, Vanelli M, Pistorio A, Minuto N, Bergamino L, Lafusco D, et al. Insulin resistance and 
secretion indexes in healthy Italian children and adolescents: a multicentre study. Acta Biomed. 
2009;80:21-8.
 35. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein 
cholesterol in plasma, without use of the preparative ultracentrifuge. ClinChem. 1972;18:499-502.
 36. Gotto AM, Jr., Bierman EL, Connor WE, Ford CH, Frantz ID, Jr., Glueck CJ, et al. Recommendations 
for treatment of hyperlipidemia in adults. A joint statement of the Nutrition Committee and the 
Council on Arteriocslerosis. Circulation. 1984;69:1065A-90A.
114 Chapter 6
 37. Bergmeyer HU, Horder M, Rej R. International Federation of Clinical Chemistry (IFCC) Scientific 
Committee, Analytical Section: approved recommendation (1985) on IFCC methods for the mea-
surement of catalytic concentration of enzymes. Part 3. IFCC method for alanine aminotransferase 
(L-alanine: 2-oxoglutarate aminotransferase, EC 2.6.1.2). JClinChemClinBiochem. 1986;24:481-95.
 38. Ou HY, Wang CY, Yang YC, Chen MF, Chang CJ. The association between nonalcoholic fatty pan-
creas disease and diabetes. PLoSOne. 2013;8(5):e62561.
 39. Saad V, Wicklow B, Wittmeier K, Hay J, MacIntosh A, Venugopal N, et al. A clinically relevant method 
to screen for hepatic steatosis in overweight adolescents: a cross sectional study. BMCPediatr. 
2015;15:151.
 40. Lee JM, Gebremariam A, Wu EL, LaRose J, Gurney JG. Evaluation of nonfasting tests to screen for 
childhood and adolescent dysglycemia. Diabetes Care. 2011;34:2597-602.
 41. Shah S, Kublaoui BM, Oden JD, White PC. Screening for type 2 diabetes in obese youth. Pediatrics. 
2009;124:573-9.
 42. Chan CL, Pyle L, Newnes L, Nadeau KJ, Zeitler PS, Kelsey MM. Continuous glucose monitoring and 
its relationship to hemoglobin A1c and oral glucose tolerance testing in obese and prediabetic 
youth. JClinEndocrinolMetab. 2015;100:902-10.
 43. Radhakishun NN, van Vliet M, von Rosenstiel IA, Weijer O, Beijnen JH, Brandjes DP, et al. Increasing 
thyroid-stimulating hormone is associated with impaired glucose metabolism in euthyroid obese 
children and adolescents. JPediatrEndocrinolMetab. 2013;26:531-7.









This thesis addresses two important issues in obesity research.  Part II reports on the 
investigations in the neural aspects of obesity, specifically their interactions with be-
haviour and genetics, to gain insight in the pathological mechanism leading to obesity, 
while the third part explores ways to improve the diagnostic strategy in children with 
obesity. 
BEhaVIOuraL anD nEuraL asPECts Of OBEsItY
Understanding the complex pathophysiology of obesity is the key in developing suc-
cessful therapies. Considering the limited success of current treatment, further under-
standing of patterns of feeding behaviour in obese people is needed to improve on 
current treatment strategies(1). In the last two decades, a substantial number of brain 
areas have been shown to be altered in size, thickness or activation in this population. 
The understanding of how these differences influence behaviour is at this moment lack-
ing. Although vast progress is made, there are still a lot of dots that need connecting. 
Feeding behaviour and weight gain in childhood are amongst the most important 
predictors of future eating behaviour and adult weight status. Therefore, understand-
ing of feeding behaviour at young age is key to the development of prevention and 
treatment strategies(2). In this respect, executive functioning is an important area of 
interest. Executive function is a collective name for self-regulatory processes(3), of which 
inhibitory control and the ability to delay gratification are most often described as being 
impaired in children with obesity(4-6). More specifically, impaired executive function 
negatively influences the outcome of treatment(7). Furthermore, children with obesity 
tend to show increased responsiveness to overeating, decreased satiety responsiveness 
and were shown to eat triggered by emotion(8).
adolescent obesity, brain structure and executive function
In chapter 2 we described the relationship between differences in brain structure and 
aspects of behaviour and showed that the pallidum is significantly larger in adolescents 
with obesity, and that pallidum size correlated with executive function in obese ado-
lescents. This finding is in line with findings that pallidum size is increased in children 
with obesity(9) and that visual food stimuli activate the pallidum to a greater extent in 
subjects with obesity, than in lean subjects(10). It was suggested that this is a sign of 
increased reward processing, while we did not find a relationship between the pallidum 
and reward driven appetitive behaviours, but with executive function. The dorsal part 
of the pallidum has extensive inhibitory GABA-ergic projections to various structures 
related to reward processing(11) and projects toward various frontal areas involved 
in exerting control over behaviour(12). This shows that different parts of the pallidum 
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might have different roles in the pathophysiology of obesity. In children and adolescents 
with ADHD, a condition known for impairment of executive function, amplitude of the 
BOLD-signal was increased in the globus pallidus, during rest(13). This might suggest 
that this is a compensatory mechanism for hypofunction of other executive areas. This 
is in line with our explanation of the larger pallidum size we found in obese adolescents. 
However, future research on the exact mechanisms and role of the pallidum in obesity 
pathophysiology is warranted.  
It would be interesting to design a study on pallidum BOLD response including high 
and low calorie food items. Furthermore, more intricate designs involving testing of 
executive function during fMRI could aid in specifically finding the domains of execu-
tive function in which the pallidum is involved. This research should not only focus on 
BOLD-response, but should also include connectivity analysis, to gain inside in the 
communication with other brain structures and networks during executive function 
tasks.  As a first step, we analysed resting state connectivity differences in obese and lean 
adolescents (chapter 3), but did not find any differences in resting state connectivity 
of the pallidum between these groups. There is a variety of reasons that could explain 
the lack of differences. The first being that the study was performed in a resting state 
only, posing the question whether differences in pallidum connectivity could arise only 
when actively engaged in either executive function or when challenged by food cues. 
Furthermore, the participants were satiated while the study was performed, possibly 
suppressing connectivity that is more pronounced when hungry. The results of our rest-
ing state study, however, are in line with research in children with ADHD, which did not 
show any alteration in functional connectivity of the globus pallidus during rest when 
compared to non-ADHD control subjects(13). These findings indicate that differences 
in pallidum function and connectivity probably arise when actively engaging in a task. 
resting brain connectivity in adolescent obesity
Although between lean and obese adolescents no difference in connectivity of the 
pallidum was found, we did find differences in resting state connectivity. In chapter 3 
we investigate differences in resting state connectivity between lean and obese adoles-
cents, of the default mode network, executive control network and salience network as 
well as connectivity differences of brain structures involved in hunger and satiation pro-
cessing (the hypothalamus), reward processing (the amygdala) and executive function 
(the pallidum), while in a fed condition. The fed condition was chosen since children and 
adolescents with obesity tend to eat in the absence of hunger, thereby exceeding caloric 
demands(14,15). This analysis showed differences in the executive control network, a 
network involved in exerting control over behaviour.  The executive control network 
showed lower connectivity in obese compared to lean adolescents specifically in the 
lateral occipital cortex, possibly indicating that visual food cues trigger areas involved 
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in controlling feeding behaviour to a lesser extent. Furthermore, we found higher con-
nectivity of the occipital pole with the salience network in obese, indicating that salient 
food signals might be processed with high priority, as was also suggested by recent 
work in obese adults(16). Previously, it was shown that the salience network showed 
increased within network connectivity in both adults with obesity and in subjects with 
Prader Willi syndrome(17, 18). This was explained as an imbalance between autonomic 
processes, such as hunger and satiety signalling, and reward processing. The results of 
chapter 3 indicate that, even at rest, the brain of obese adolescents is programmed to 
prioritise salient food cues, thereby overriding satiety signalling, while simultaneously 
triggering areas involved in exerting control over food intake to a lesser extent than 
in lean subjects. In line with our findings, it was recently shown that fed adolescents 
with obesity show decreased resting state connectivity between the insula, part of the 
salience network, and the dorsolateral prefrontal cortex, a key area in cognitive control 
over food intake(19). This indicates that, in adolescent obesity, there is an imbalance 
between salience processing and the executive control over these processes, providing 
a framework for the possible mechanism that explains why adolescents with obesity eat 
in the absence of hunger. 
Still, a lot of questions remain unanswered. Differences in resting state connectivity do 
not tell us how they affect behaviour. Therefore, future work should focus on investigat-
ing processing of food cues using connectivity analysis to find what happens when visual 
information is forwarded to the salience and executive control network. Furthermore, it 
would be of interest to repeat our investigation in a state of hunger, to explore if there 
are different mechanisms in a non-satiated state that might contribute to obesity. Most 
importantly, the question we must ask is whether we can influence this brain activity 
and ultimately improve treatment outcome. Regarding this question, it is of interest that 
executive function training, using inhibitory control and working memory tasks, was 
able to help children lose more weight and maintain weight loss(20).  Combining these 
trainings with longitudinal fMRI data could further aid to the understanding of changes 
in executive function present in children with obesity. All in all, chapter 2 and 3 provide 
valuable new insights in executive dysfunction of adolescents with obesity.
Looking at the behavioural data presented in chapter 2, one of the most remark-
able aspects is the variability of the data. Some adolescents with obesity performed 
markedly worse on executive function testing, while others performed at or above the 
average of their lean peers.  In the latter group, other mechanisms than impaired execu-
tive function, seem to cause alternative feeding patterns ultimately leading to obesity. 
This is in line with the experience of healthcare workers, who see a marked difference 
in reaction to treatment between those who suffer from, for example, binge eating and 
children who have a sedentary lifestyle. More carefully defining different behavioural 
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phenotypes leading to obesity could aid in future research and ultimately aid treatment 
outcome. 
ftO and the reward system  
Another matter of concern is that we do not fully understand the underlying cause of 
differences in brain structure and function. This knowledge can be crucial in preven-
tion and treatment strategies. It has been put forward that structural brain changes are 
primarily caused by metabolic derangement(21, 22), thereby suggesting that ‘nurture’ is 
the major driver of alterations in brain structure and ultimately function. In this regard, 
however, it should be noted that overwhelming progress was made in understanding 
how genetics relate to our body composition in the last two decades. Genetic studies 
in body composition, led to the identification of various genes that are associated with 
BMI. Some rare mutations, such as mutations in the melanocortin-4-receptor gene, 
have been shown to be associated with marked hyperphagia and strongly increased 
weight(23), while more common variants, such as the fat-mass-and-obesity-associated 
gene (FTO) showed smaller effects, but affect a much larger part of the population(24), 
hereby showing that ‘nature’ also adds to the equation. 
The FTO gene was identified in one of the first genome wide association studies on 
body composition(24).  In a western population, people homozygous for the A risk allele 
on rs9939609 were on average 3 kg heavier, and people heterozygous for this allele were 
on average 1.7 kg heavier than people who were homozygous for the wildtype T allele. 
With 16% of the population in this study being homozygous for the risk allele, and 47% 
being heterozygous for this allele, these effects, although small, affect a large portion 
of the population. Therefore, understanding the mechanisms through which FTO influ-
ences body weight, is crucial. 
It was previously shown that FTO encodes a 2-oxoglutarate-dependent nucleic acid 
demethylase(25) and that FTO-gene overexpression leads to increased production of 
ghrelin, a hunger inducing hormone produced in the stomach, thereby influencing the 
endocrine communication to the hypothalamus, which is the centre of hunger and sa-
tiety signalling(26). These factors only partially explain behavioural patterns associated 
with the risk allele. They do, however, not explain the relationship of FTO with emotional 
eating and loss of eating control(27-29), suggesting that higher brain functions were 
affected as well. In chapter 4, the relationship between the FTO-gene risk allele and 
brain structure was described. Our data show that the FTO risk allele is associated with 
changes in the dopaminergic reward system. More specifically, the FTO-gene was as-
sociated with a smaller volume of the nucleus accumbens, independent of BMI. This 
suggests that FTO does not only affect hunger and satiety signalling but also reward 
processing. Moreover, it was shown that nucleus accumbens responses to hedonic 
food pictures were different between risk allele and non-risk allele carriers(30) and that 
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knockout of FTO dysregulated dopamine receptor-dependent control of neuronal activ-
ity in the nucleus accumbens(31). 
More recent reports on FTO have shown that, even in childhood, FTO-genotype is 
related to appetitive behaviours. It was shown that not only decreased satiety respon-
siveness, but also increased food responsiveness modulated the relationship between 
FTO risk allele carriers and BMI. This further underlines that FTO alters reward signalling, 
even at young age(32). Moreover, it was shown that children with AA genotype have 
increased nucleus accumbens activity while viewing food commercials, suggesting 
increased responsiveness to rewarding food cues(33). Interestingly, in contrast to the 
results reported in chapter 4 this latter study found higher volume of the nucleus ac-
cumbens in children, suggesting that FTO might influence the rate of neural develop-
ment at young age, leading to atrophy at later age. Recent fMRI studies in adults have 
suggested that FTO does not only influence reward processing, but also mediates sa-
lience processing of food cues and activity of frontal regions involved in exerting control 
over food intake(34, 35). In summary, combined with the results presented in this thesis, 
the current literature shows that FTO influences brain areas involved in various aspects 
of feeding behaviour, not only hunger and satiety signalling.
The question remains how pathophysiological knowledge on FTO can improve cur-
rent treatment. Given the differential patterns in feeding behaviour of risk allele carri-
ers shown in previous work, one can argue that, in the future, it would be particularly 
interesting to learn how differences in FTO genotype influences treatment outcome in 
different treatment regiments. Then, ultimately, with declining costs of genetic testing, 
genotyping FTO could aid in treatment selection for people burdened with obesity. 
DIaGnOstIC WOrkuP Of OVErWEIGht PaEDIatrIC PatIEnts In CLInICaL 
PraCtICE
Bone age advancement in obese paediatric patients  
Clinicians involved in the diagnostic workup of children with obesity are frequently 
encountered with the challenge of assessing whether obesity is caused by unhealthy 
feeding habits solely, or whether underlying pathology contributes to obesity. Endo-
crine, syndromic and genetic conditions have been shown to influence bodyweight(23, 
36-38). Prevalence of these condition, however, is low. Assessment of growth, puberty 
and bone age have a central place in the diagnostic workup for finding underlying pa-
thology in obese children. The most challenging aspect of the workup in children with 
obesity is that bone age and growth in height are often advanced without underlying 
pathology(39-44). Former research has shown various possible factors that influence 
bone age maturation, including androgens, oestrogens and insulin(39-44). These stud-
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ies, however, show variable results, possibly due to the variability in these hormones 
throughout childhood. Therefore, chapter 5, of this thesis describes the relationship 
between androgens, oestrogens and parameters of insulin resistance with bone age. 
This study improved on former research by using age and sex specific SDS scores for 
androgens, oestrogens and bone age. It was shown using multiple regression analysis 
that increased levels of dehydroepiandrosteron-sulphate (DHEAS) are independently 
associated with bone age advancement. This suggests that increased production of 
androgens by the adrenal gland plays a central role in the advanced bone age and 
concomitant accelerated growth in height. This is in line with a study performed in the 
past(45). The pathophysiological mechanism through which increased DHEAS levels 
influence bone age, are likely to be indirect. A plausible mechanism is that increased 
production of DHEA, of which DHEAS is the inactive derivative, causes higher peripheral 
conversion to oestradiol, thereby accelerating bone maturation(45). 
It has to be noted that the model derived from multiple regression analysis only 
explained a maximum of 31% of the variance in bone age SDS, indicating that other 
factors are involved in bone age advancement. Of the factors included in this study, 
it is of interest that oestrogen, testosterone and parameters of insulin resistance were 
not related to bone age, while other studies suggest a relationship(42-46). This could 
be due to the, although widely used in clinical practice, insensitive assays for oestradiol 
and testosterone used and the fact that we were unable to calculate SDS scores for the 
insulin parameters. Alternatively, other factors could contribute to advanced bone age, 
such as leptin and IGF-1(42, 47), although some research suggests that there is no rela-
tionship(45). Again, calculation of age and sex specific SDS scores could aid in clarifying 
this matter. 
An interesting secondary result of this study was that the small number of children 
with suspected monogenic obesity did not seem to differ in bone age SDS or accelerated 
height, possibly suggesting that similar mechanisms induce advancements in growth 
and bone maturation. This group, however, was too small to draw conclusions consider-
ing the precise mechanisms that underlie bone age advancement in these children. 
In conclusion, the results of this part of the thesis suggest that in obese children with 
accelerated growth in height, combined with advanced bone age and high levels of 
DHEAS, preferably expressed as SDS, clinicians can consider abstaining from further di-
agnostic workup. The results of this study suggest that if a patient has increased height 
and/or bone age SDS, but lacks high levels DHEAS, further investigations are warranted. 
However, to make this applicable in clinical practice further research should determine 
reference ranges for DHEAS SDS in relation to bone age SDS. 
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Predicting impaired glucose tolerance
There is an ongoing debate among clinicians considering the diagnostic work-up of 
co-morbidity screening in overweight and obese children. This discussion is caused by 
the need to diagnose children with a high risk of co-morbidity, such as patients with 
impaired glucose tolerance, on the one hand, and the low diagnostic yield and high 
costs of performing an extensive diagnostic work-up in all obese children, on the other 
hand. The reason that identifying glucose derailment early, specifically impaired glucose 
tolerance, is deemed so crucial, is that it increases the chance of developing type 2 dia-
betes early in life(48, 49).  Therefore, current guidelines recommend intensive treatment 
and stricter follow up of children with impaired glucose tolerance(50). The problem 
with identifying children with impaired glucose tolerance is that it is diagnosed via oral 
glucose tolerance testing (OGTT), which is an invasive and time consuming procedure 
compared to taking a single blood sample in a fasted condition. Therefore, the current 
Dutch guideline prescribes assessing fasting glucose as a first step of the diagnostic 
process(50). If fasting glucose is >5.6 mmol/L, further diagnostics, such as OGTT, should 
be considered. A vast body of research, however, suggests that the strategy of testing 
fasting glucose to assess whether further diagnostics are needed misses most cases of 
impaired glucose tolerance(51-57). Therefore, chapter 6 was dedicated to investigating 
whether a combination of simple and cheap parameters, available in everyday practice, 
could improve the sensitivity of the diagnostic approach. The results indicate that com-
bining fasting glucose with the presence of hypertension and elevation in liver enzymes 
could significantly improve the sensitivity of finding impaired glucose tolerance, with an 
acceptable number needed to treat of 5.7. If this finding can be replicated in a second 
cohort, we would advocate to adjust current guidelines, suggesting to screen for pa-
tients at risk for DM with fasting glucose, blood pressure and liver enzymes to evaluate 
whether they are at increased risk for glucose derailment.
Of specific interest is the finding that a combination of the presence of hypertension 
and elevated liver enzymes also improved sensitivity, since they are parameters that do 
not require fasted blood sampling. Development of a diagnostic strategy that waives 
the need for fasted sampling could improve healthcare logistics, and improve the conve-
nience of patients. Further improvement on this strategy could be found by adding new 
parameters. In this respect, developments in diabetic adults are of particular interest. 
In recent years, parameters of systemic inflammation, such as high sensitive C-reactive 
protein and interleukin 6 have been shown to correlate with type II diabetes in young 
adult men(58). Given that obese children show signs of systemic inflammation(59), it 
would be interesting to investigate if they improve the predictive model. 
Furthermore, taking individual feeding patterns could be promising for future diag-
nostic strategies. Recently, for example, it was shown that binge eating can significantly 
impair insulin sensitivity in healthy young adults(60), showing that individual feeding 
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patterns, independent of the quantity of calories consumed, might play a role in meta-
bolic derailment found in obesity. To date, however, this has not been investigated in 
obese children.    
In conclusion, screening patients with either elevated blood pressure, elevated liver 
enzymes and/or impaired fasting can significantly improve the sensitivity of finding 
children with impaired glucose tolerance and thereby improve the diagnostic strategy, 
compared to the current guideline.
COnCLusIOns anD futurE rECOMMEnDatIOns
This thesis describes investigations into two aspects of obesity research. The first part 
is dedicated to investigating neural pathophysiological mechanisms contributing to 
obesity. In this section, it was shown that pallidum size is increased in adolescent obesity 
and that higher pallidum size is linked to better ability to delay gratification and better 
inhibitory response in adolescents with obesity (chapter 2). Furthermore, in chapter 
3, it was shown that resting state connectivity within the executive control network in 
the lateral occipital gyrus was decreased in obese participants, possibly showing that 
visual cues might not trigger executive control areas to the same extend as in their 
lean pears.  These data also showed increased connectivity between the primary visual 
fields and the salience network in adolescent obesity, suggesting that the brain of these 
youngsters is continuously programmed to forward visual food cues with preference. 
The obesity associated gene, FTO, is associated with nucleus accumbens volume in 
chapter 4 showing that the FTO gene is also involved in reward processing, in addition 
to hypothalamic processing of satiety and hunger. 
The second part of this thesis is dedicated to improving the diagnostic strategy of chil-
dren and adolescents with obesity. Chapter 5 presents detailed and extensive data on 
the correlation of various endocrine measures with bone age advancement and shows 
that DHEAS is a key component in the pathophysiological mechanism of advanced bone 
age. Finally, the results of Chapter 6 show that performing oral glucose tolerance testing 
in all children with either elevated blood pressure, elevated liver enzymes or impaired 
fasting glucose significantly improves the sensitivity of the diagnostic strategy to find 
impaired glucose tolerance, compared to the current strategy.
Considering the results of this thesis, future research should focus on investigating the 
role of the pallidum in executive dysfunction, specifically by applying fMRI-task designs 
testing various domains of executive function, preferably in subgroups based on feeding 
patterns and executive dysfunction. Furthermore, task based connectivity studies are 
needed to improve knowledge on how different areas of the occipital lobe interact with 
executive function and salience signalling. Considering the new knowledge on the role 
General discussion 129
7
FTO plays in brain signalling, future studies should define groups of obese subjects with 
specific feeding patterns associated with presence of the FTO risk allele, and investigate 
BOLD-response and connectivity differences during tasks that test reward responsivity. 
To gain more insight in the pathophysiology of advanced bone age, it is important that 
future studies include additional parameters and use ultrasensitive assays to detect vari-
ance in hormonal levels, since some hormonal levels are undetectable by assays avail-
able in clinical practice. Furthermore, it is crucial to calculate age and sex specific SDS to 
overcome the challenge of hormonal variance throughout childhood and adolescence. 
Research on diagnostic strategies to detect glucose derailment early, should investigate 
predictive models including multiple parameters. Furthermore, investigation of feeding 
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The aim of this thesis is to gain insight in two important aspects of human obesity. First, 
it aims to investigate structural and functional differences between subjects with and 
without obesity, specifically the relationship between these differences and behaviour 
and genetics. Secondly, it investigates the diagnostic strategy for finding causes and 
consequences of obesity in children, aiming to improve this strategy. 
Chapter 1 provides an introduction into the research described in this thesis.
Chapter 2 reports on structural differences in subcortical and cortical brain structures 
involved in reward behaviour and executive function (brain functions involved in self-
regulation) in adolescents with and without obesity and the relationship of these dif-
ferences with behaviour. 44 adolescents (25 with obesity and 19 without obesity, aged 
12-16 years) underwent an MRI-scan of their brain. The volume of various subcortical 
brain structures, involved in reward behaviour, as well as cortical thickness of structures 
involved in executive function, were measured. Furthermore, eating behaviour was 
investigated using a parental questionnaire (the Child Eating Behaviour Questionnaire) 
and executive functions were assessed using two tasks. The first was a Stop-Signal-Task, 
in which the ability to inhibit a impulsive response is tested. The second task was a Choice 
Delay Task, with which the ability to choose a larger, delayed reward over a smaller direct 
reward was tested. On both tasks it was shown before that children with obesity score 
lower than their lean peers. The results of this part of the thesis showed larger pallidum 
size in children with obesity (p=0.014, FDR corrected) and a larger amygdala in the un-
corrected analysis (p=0.03). Specifically in the group of subjects with obesity, a positive 
association was found between pallidum size and the results of the Choice Delay Task 
(p=0.012). Furthermore, a marginally significant negative correlation between results 
of the Stop Signal Task and pallidum volume (p=0.055) were found. Given that a lower 
score on the Stop Signal Task means that the ability to inhibit responses is better, the 
latter result also indicated that larger pallidum volume was associated with better task 
performance. The pallidum has many functions. For this research it is interesting to know 
that the pallidum has an inhibitory influence on other reward related structures and is 
directly connected to several frontal lobe structures involved in executive function. The 
results of our research suggest that the overall larger pallidum size in these adolescents 
might be an adaptive mechanism in patients with obesity, aiming to control uninhibited 
feeding behaviour. In adolescents with obesity and larger pallidum volume it appears, 
given the results of neuropsychological testing, that this mechanism has developed 
more successfully. Further research, for instance using fMRI, could help to gain more 
insight in the specific mechanism through which the pallidum influences executive 
function.  
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Chapter 3  describes the findings of research dedicated to exploring differences in 
functional brain connectivity between adolescents with and without obesity. In connec-
tivity research, the degree of synchronous activity of a brain structure or brain network 
with other brain structures or networks is investigated. This is used as a proxy of com-
munication between brain structures and/or networks and is usually measured either 
while performing a task or in rest. In this chapter, the connectivity of 32 adolescents (17 
with and 15 without obesity, 12-16 years in age) are investigated in rest, while satiated. 
These investigations were on the connectivity of three brain structures: the amygdala 
(involved in reward processing), the pallidum (involved in executive function) and the 
hypothalamus (involved in hunger and satiety signalling). In addition, the connectiv-
ity of three networks was explored: the default mode network (mainly active during 
wakeful rest), the executive control network (involved in executive function) and the 
salience network (active when salient events occur in ones environment). In this study 
it was shown that adolescents with obesity have less functional connectivity in the 
executive control network of a part of the occipital lobe (the lateral occipital cortex) 
with the rest of the executive control network. This might suggest that this part of the 
brain, when triggered by visual food stimuli, activates the rest of the executive control 
network to a lesser extent. Furthermore, in adolescents with obesity, another part of the 
occipital lobe, the occipital pole, had increased connectivity with the salience network. 
This indicates that even in a resting state, the brain of these adolescents is programmed 
to process visual (food) cues with priority and give more attention to them. In conclu-
sion, in adolescents with obesity, there appears to be a disturbed balance, even in rest 
and when satiated, with the brain being in a constant state of visual information being 
regarded more salient and triggering the part of the brain that exerts control over ones 
actions to a lesser extent.   
Variants in the FTO gene have been associated with higher body weight in a wide 
variety of populations. Studies investigating the pathophysiological mechanism have 
thus far shown that these variants are associated with alterations in hunger and satiety 
signalling. There are, however, indications that FTO variants also affect subcortical and 
cortical signalling. This led to the investigations described in chapter 4 in which the re-
lationship between the FTO risk allele, RS9939609A, and reward related brain structures 
was studied in a group of 492 elderly participants, in which MRI and FTO genotyping 
were performed. It was shown that subjects homozygous for the risk allele A had signifi-
cantly smaller volume of the nucleus accumbens those homozygous for the wild type 
T allele. This relationship was independent of BMI. Hereby it was shown that FTO does 
not only affect hunger and satiety signalling, but also effects reward related behaviour. 
The results of investigation in to the pathophysiological mechanism driving advanced 
bone age in children with obesity are described in chapter 5. In many children with 
obesity, growth in height as well as bone age are advanced. In this patient category, it 
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is challenging for clinicians to determine whether these advancements can be contrib-
uted solely to obesity, or whether an endocrine or genetic cause should be considered. 
Therefore, more knowledge on the pathophysiological mechanism driving bone age 
advancement is necessary. In a total of 101 children with obesity, bone age was deter-
mined using an X-ray of the wrist and extensive endocrine testing was performed.  The 
results showed that BMI SDS is, as expected, strongly correlated with bone age SDS. 
In multiple regression analysis, it was shown that dehydroepiandrosteron sulphate 
(DHEAS) SDS correlated independently with bone age SDS in the total cohort, as well as 
in subgroups based on sex and pubertal status. A possible pathophysiological explana-
tion for the relationship between the concentration of DHEAS and advanced bone age is 
that DHEAS signals high levels of DHEA, which is converted at tissue level to oestrogens, 
thereby contributing to faster maturation of the bone. This research suggests that in 
paediatric patients with obesity and an advanced bone age and isolated rise in DHEAS, 
clinician can consider refraining from further diagnostic testing. 
Chapter 6 is dedicated to early detection of impaired glucose tolerance and diabetes 
in children who are overweight or obese. The current Dutch CBO guideline recommends 
that children who are overweight or obese should be evaluated by an oral glucose toler-
ance test (OGTT) to rule out impaired glucose tolerance (IGT; two hour glucose in OGTT 
≥ 7,8 mmol/L but < 11,1 mmol/L) or diabetes (two hour glucose in OGTT ≥ 11,1 mmol/L) 
if they have impaired fasting glucose (fasting glucose ≥ 5,6 mmol/L but < 7,0 mmol/L). 
A substantial amount of evidence has shown that this strategy misses a significant 
number of cases of IGT and diabetes. Therefore, we investigated whether combining 
diagnostic parameters, available in everyday practice, could improve the sensitivity of 
detecting patients with glucose derailment. In this study, a total of 145 overweight or 
obese paediatric patients the anthropometric data, fasting blood sample and OGTT data 
were analysed. It was shown that when all children with either elevated blood pressure, 
elevated liver enzymes or impaired fasting glucose were tested by OGTT sensitivity for 
detecting IGT would increase from 0.18 to 1.00. Given the fact that IGT in childhood, 
particularly in patients with ongoing increase in BMI, is predictive of diabetes in (young) 
adulthood, we advise, if our findings can be replicated in an independent cohort, to 
adjust the CBO guideline. 
Chapter 7 contains the general discussion and conclusion of this thesis. It also gives 
suggestions for future research in the neuropathophysiology of obesity as well as the 






Het doel van dit proefschrift is om inzicht te vergaren in twee belangrijke aspecten van 
obesitas. Ten eerste heeft het als doel te onderzoeken wat de structurele en functionele 
verschillen in het brein zijn tussen mensen met en zonder obesitas, in het bijzonder 
de relatie tussen deze verschillen met genetica en gedrag. Ten tweede onderzoekt het 
de diagnostische strategie voor het vinden van oorzaken en gevolgen van obesitas bij 
kinderen, om zodoende deze strategie te optimaliseren.
hoofdstuk 1 Bevat een introductie met betrekking tot de in dit proefschrift bes-
chreven onderzoeken. 
hoofdstuk 2 rapporteert over de structurele verschillen in subcorticale en corticale 
breinstructuren die betrokken zijn bij beloningsgedrag en executieve functies (brein-
functies waarmee controle over gedrag wordt uitgeoefend) in adolescenten met en 
zonder obesitas en de relatie van deze structuren met gedrag. 44 adolescenten (25 met 
obesitas en 19 slanke controle proefpersonen, 12-16 jaar) kregen een MRI-scan van het 
brein, waarbij de volumina van een aantal subcorticale structuren, betrokken bij belon-
ingsgedrag, werden gemeten. Verder werd de dikte van de hersenschors gemeten van 
een aantal corticale structuren die betrokken zijn bij controle over gedrag. Daarnaast 
werd eetgedrag op verschillende aspecten gescoord met een vragenlijst die door de 
ouders van de deelnemers werd ingevuld (de Child Eating Behaviour Questionaire; 
CEBQ) en werden de executieve functies getest met een tweetal taken. De eerste betrof 
een stop-signaal-taak, waarbij het vermogen tot remming van een impulsieve respons 
wordt getest. De tweede betrof een uitgestelde-beloning-taak, waarmee het vermogen 
om een grote, uitgestelde beloning te verkiezen boven een kleine, directe beloning 
wordt getest. Zowel van responsinhibitie als van het vermogen om beloning uit te 
stellen is eerder aangetoond dat kinderen en adolescenten met obesitas hier lager op 
scoren. De resultaten van dit onderzoek toonden dat het pallidum, een subcorticale her-
senstructuur betrokken bij beloningsgedrag, van adolescenten met obesitas significant 
groter is (p=0.014, FDR gecorrigeerd) en dat de amygdala, een subcorticale hersenstruc-
tuur betrokken bij beloningsgedrag en angst, in de ongecorrigeerde analyse groter was 
in deze groep (p=0.03). Specifiek in de groep proefpersonen met obesitas werd voor 
het pallidum een positieve associatie gevonden met de uitkomst van de uitgestelde-
beloning-taak; in deze groep was een groter volume van het pallidum gecorreleerd 
met een hogere score op de uitgestelde beloning taak (p=0.012). Daarnaast was er een 
negatieve correlatie tussen de uitkomst van de stop-signaal-taak en het volume van het 
pallidum met een trend naar significantie (p=0.055). Omdat een lage score op de stop-
signaal-taak een betere responsinhibitie inhoud, was er ook hier sprake van dat een 
groter volume van het pallidum geassocieerd is met een betere uitkomst van de taak. Het 
pallidum heeft vele functies. Een van de voor dit onderzoek interessante functies is dat 
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het een remmend effect heeft op andere structuren van het beloningssysteem en ook 
directe verbindingen heeft met diverse structuren van de frontaalkwab, die betrokken 
zijn bij de controle van het gedrag. De uitkomsten van dit onderzoek suggereren dat 
het algeheel grotere volume van het pallidum bij adolescenten met obesitas mogelijk 
een adaptatie is, als contramechanisme tegen ontremd eten. Bij adolescenten met obe-
sitas bij wie het pallidum volume groter is, lijkt, in neuropsychologisch onderzoek, dit 
corrigerend mechanisme beter te zijn ontwikkeld. Verder onderzoek, bijvoorbeeld met 
functionele MRI, zal in de toekomst moeten uitwijzen wat het specifieke mechanisme is 
waarmee het pallidum executieve functies beïnvloed. 
hoofdstuk 3 beschrijft de bevindingen van onderzoek naar verschillen in connectivit-
eit in het brein tussen adolescenten met en zonder obesitas. Bij connectiviteitsonderzoek 
wordt van een breinstructuur, of netwerk van breinstructuren, de mate waarin activiteit 
synchroon met andere structuren optreedt bepaald. Hieruit wordt communicatie tussen 
breinstructuren of netwerken, bij het uitvoeren van een taak, of juist in rust, afgeleid. In 
dit onderzoek werden 32 adolescenten (17 met obesitas en 15 slanke controle proefper-
sonen, 12-16 jaar) gescand in rust, kort na het ontbijt. Er werd gekeken naar de connec-
tiviteit van 3 hersenstructuren namelijk: de amygdala (belangrijk bij beloningsgedrag), 
het pallidum (betrokken bij executieve functies) en de hypothalamus (betrokken bij 
het signaleren van honger en verzadiging). Daarnaast werd de connectiviteit bepaald 
van 3 netwerken aan breinstructuren, namelijk het default mode netwerk (vooral actief 
wanneer men niet met een specifieke taak bezig is), het executieve controle netwerk 
(betrokken bij controle over gedrag) en het salience netwerk (actief bij het signaleren 
van opvallende gebeurtenissen). In dit onderzoek werd aangetoond dat een deel van 
de occipitaalkwab (de visuele hersenschors) binnen het executieve controle netwerk, 
minder connectiviteit vertoonde met de rest van het netwerk bij adolescenten met 
obesitas. Dit suggereert mogelijk dat visuele informatie (zoals het zien van voeding), 
die via de visuele hersenschors binnenkomt, de gebieden die gaan over controle van 
gedrag minder activeren bij adolescenten met obesitas. Daarnaast werd gezien dat een 
ander deel van de occipitaalkwab sterkere connectiviteit had met het salience netwerk 
in de groep adolescenten met obesitas. Dit doet vermoeden dat het brein van deze ado-
lescenten, zelfs in rust en terwijl een proefpersoon wel gevoed is, vatbaar is om visuele 
prikkels, zoals visuele voedselprikkels, extra aandacht te geven. Concluderend lijkt het 
erop dat, zelfs in rust en terwijl er geen honger wordt ervaren, het brein van adoles-
centen met obesitas geprogrammeerd is om visuele voedselprikkels meer aandacht te 
geven en over het binnen komen van die prikkels minder controle uit te oefenen. 
In hoofdstuk 4 wordt de relatie beschreven tussen een gen waarvan is aangetoond 
dat varianten in dit gen leiden tot een hoger gewicht (het, fat-mass-and-obesity-
associated gen of  FTO-gen) en volumes van het beloningssysteem in het brein. Eerder 
werd in een aantal studies aangetoond dat het FTO-gen invloed had op het signaleren 
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van honger en verzadiging. In het in dit proefschrift beschreven onderzoek werd in 
een groep van 492 ouderen, waarbij zowel een MRI was gemaakt als genotypering van 
FTO had plaatsgevonden, aangetoond dat mensen met twee A risicoallelen op positie 
RS9939609 een significant kleinere nucleus accumbens, een subcorticale hersenkern 
met een centrale rol in beloningsgedrag, hebben dan mensen met twee T wild type 
allelen. Deze relatie was onafhankelijk van BMI. Hiermee werd aangetoond dat niet 
alleen de signalering van honger en verzadiging wordt beïnvloed door FTO, maar dat 
waarschijnlijk ook beloningsgedrag wordt beïnvloed door FTO.  
De resultaten van het onderzoek naar het pathofysiologische mechanisme achter 
voorlopende botleeftijd bij kinderen met obesitas zijn beschreven in hoofdstuk 5. Bij 
veel kinderen met obesitas is sprake van voorlopende lengtegroei ontwikkeling ge-
combineerd met voorlopende skeletleeftijd. Voor clinici is het moeilijk om bij kinderen 
met obesitas, die zowel voorlopen in lengtegroei als in skeletleeftijd te bepalen of dit 
het gevolg is van obesitas, of dat er ook een endocriene of genetische oorzaak over-
wogen moet worden. Daarom is meer inzicht in de pathofysiologie van dit verschijnsel 
wenselijk. In totaal werd bij 101 kinderen met obesitas de skeletleeftijd bepaald met 
een röntgenfoto en werd uitgebreid bloedonderzoek verricht. Er werd aangetoond dat 
BMI SDS sterk gecorreleerd is met skeletleeftijd SDS. In multipele regressieanalyse werd 
aangetoond dat dehydroepiandrosteron sulfaat (DHEAS) SDS in het totale cohort, maar 
ook in de subgroepen met vrouwelijke, mannelijke en pubertaire patiënten onafhan-
kelijk positief gecorreleerd is met skeletleeftijd SDS. Een mogelijke pathofysiologische 
verklaring voor de relatie tussen hogere concentraties DHEAS en voorlopende skelet 
is dat hoge concentratie DHEAS een indirect gevolg zijn van een hoge concentratie 
dehydroepiandrosteron (DHEA), wat op weefselniveau in de botten wordt omgezet naar 
oestrogenen, die weer zorgen voor een snellere uitrijping van het bot. Dit onderzoek 
suggereert dat bij patiënten met obesitas en een voorlopende botleeftijd, met bij ini-
tieel onderzoek alleen een verhoogd DHEAS, wellicht afgezien kan worden van verdere 
diagnostiek. 
In hoofdstuk 6 worden de resultaten beschreven van onderzoek naar vroege detectie 
van verminderde glucosetolerantie (Engels: impaired glucose tolerance, afgekort IGT) 
van kinderen met overgewicht en obesitas. De huidige CBO richtlijn adviseert bij kin-
deren met overgewicht en obesitas aanvullend onderzoek middels een orale glucose 
tolerantie test  (OGTT) te doen naar IGT (twee-uurs glucose in OGTT ≥ 7,8 mmol/L maar 
< 11,1 mmol/L) en diabetes (twee-uurs glucose in OGTT ≥ 11,1 mmol/L) bij patiënten 
die een verhoogd nuchter glucose hebben (nuchter glucose ≥ 5,6 mmol/L maar < 7,0 
mmol/L). Een omvangrijke hoeveelheid literatuur laat zien dat met deze strategie veel 
gevallen van (vroege) glucoseontregeling worden gemist. Derhalve werd onderzocht 
of het combineren van gegevens, die bij pediatrische patiënten met obesitas standaard 
gescreend worden, een betere detectie van glucose ontregeling oplevert. In totaal 
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werden van 145 pediatrische patiënten met overgewicht en obesitas de antropome-
trische gegevens, gegevens van nuchtere screening en orale glucose tolerantie testen 
geanalyseerd. Hierbij werd gevonden dat wanneer alle kinderen met een verhoogde 
bloeddruk boven de p95 of verhoogde levertransaminasen of verhoogde nuchtere 
glucose waarden onderzocht zouden worden middels OGTT, de sensitiviteit voor het 
vinden van IGT zou stijgen van 0,18 naar 1,00. Gezien het feit dat aanwezigheid van 
IGT op de kinderleeftijd, zeker als BMI stijgt, voorspellend is voor diabetes mellitus op 
(jong) volwassenleeftijd, adviseren wij, indien deze resultaten in een onafhankelijk 
cohort gerepliceerd kunnen worden, de richtlijn aan te passen en alle kinderen met 
verhoogde bloeddruk, of verhoogde levertransaminasen of verhoogd nuchter glucose 
te onderzoeken middels OGTT.
hoofdstuk 7 bevat een algemene discussie en conclusie van dit proefschrift. Ook 
schetst het de toekomstperspectieven voor het onderzoek naar de neurologische 






PuBLICatIELIjst C.j. DE GrOOt
1. Maas L, Dorigo-Zetsma JW, de Groot Cj, Bouter S, Plotz FB, van Ewijk BE. Detection 
of intestinal protozoa in paediatric patients with gastrointestinal symptoms by mul-
tiplex real-time PCR. Clin Microbiol Infect. 2014;20:545-50.
2. de Groot Cj, van den Akker ELT, Rings E, Delemarre-van de Waal HA, van der Grond J. 
Brain structure, executive function and appetitive traits in adolescent obesity. Pediatr 
Obes. 2017;12:e33-e6.
3. de Groot Cj, Rings EHHM, Barkeij Wolf JJH, Rombouts SARB, Delemarre-van de Waal 
HA, van den Akker ELT, van der Grond J. Differences in functional brain connectivity 
between adolescents with and without obesity in a fed condition. Submitted.
4. de Groot Cj, Felius A, Trompet S, de Craen AJ, Blauw GJ, van Buchem MA,  Dele-
marre-van de Waal HA, van der Grond J. Association of the fat mass and obesity-
associated gene risk allele, rs9939609A, and reward-related brain structures. Obesity. 
2015;23:2118-22.
5. de Groot Cj, van den Berg A, Ballieux B, Kroon HM, Rings E, Wit JM, van den Akker 
EL. Determinants of Advanced Bone Age in Childhood Obesity. Horm Res Paediatr. 
2017;87:254-63.
6. de Groot Cj, van der Grond J, Delgado Y, Rings EH, Hannema SE, van den Akker EL. 
High predictability of impaired glucose tolerance by combining cardiometabolic 
screening parameters in obese children. J Pediatr Endocrinol Metab. 2017;30:189-96.
Bijdrage aan boeken
1. de Groot Cj, Felius A. Obesitas bij kinderen.  Boek uitgegeven naar aanleiding van 
NERASS congres 2011. 2012. p. 65-70.
Dankwoord 153
DankWOOrD
Onderzoek kan alleen tot stand komen met de hulp van vele andere mensen. Allereerst 
ben ik natuurlijk dank verschuldigd voor de bereidheid van patiënten, proefpersonen en 
hun ouders om deel te nemen aan de onderzoeken in dit proefschrift. Daarnaast ben ik 
dank verschuldigd aan veel mensen die in meer of mindere mate hebben bijgedragen 
aan de totstandkoming van dit proefschrift, waarvan ik er een aantal in het bijzonder wil 
bedanken: 
Prof. dr. H.A. Delemarre-van de Waal, lieve Henriette, ik had deze dag heel graag met 
jou beleefd, maar het mag helaas niet zo zijn. Ik kan je niet voldoende bedanken voor de 
kansen die je me bood, de begeleiding, ondanks je ziekte, en het vertrouwen dat je in 
me stelde. Dank voor alles wat je me hebt gegeven. 
Prof. dr. E.H.H.M. Rings, beste Edmond, dank voor je bereidheid om na het wegvallen 
van Henriette mij als promovendus onder je hoede te nemen. Je sturing, brede blik op 
het geheel en soms een duwtje in de goede richting waren heel waardevol. 
Dr. E.L.T. van den Akker, beste Erica, ik ben dankbaar dat jij mijn begeleidingsteam 
bent komen versterken. Niet alleen je kunde, maar vooral je drive en positivisme maken 
je tot een bijzondere begeleider en een bijzonder mens.  Die eigenschappen hebben me 
er op de moeilijke momenten tijdens dit traject doorheen geholpen. Veel dank daarvoor. 
Dr. J. van der Grond, beste Jeroen, wat kan er veel gebeuren in 5 jaar tijd. Ondanks 
het feit dat het hele begeleidingsteam op z’n kop ging en plannen moesten worden 
bijgesteld bleef jij in oplossingen en mogelijkheden denken. Dank voor je pragmatische 
blik en je humor, ze hebben me er doorheen geholpen als het even tegen zat. 
Drs. A. Felius, beste Bram, dank voor je bereidwilligheid dit traject samen met mij op 
te starten en voor alles wat ik van je heb mogen leren als deskundige in dit vakgebied. 
Prof. dr. F.J. Walther, beste Frans, dank dat je bereid was om tijdens de afwezigheid van 
Henriette het promotorschap tijdelijk over te nemen.  
Tom, je was een goed en recht door zee mens, met hart voor de afdeling, je collega’s 
en de zorg voor zieke kinderen. Dank voor het wegwijs maken binnen het LUMC en alle 
mooie momenten op het water. 
Noor Rikkers, al 7 jaar mijn mentor, dank dat je deur altijd open stond als het nodig 
was. 
Frans Smiers, dank voor coaching, tot ver buiten de landsgrenzen. 
Alle coauteurs in dit proefschrift wil ik bedanken voor hun bijdrage aan de manuscrip-
ten. 
Prof. Jan Maarten Wit, dr. Wilma Oostdijk, dr. Sabine Hannema en dr. Christian de 
Bruin dank voor jullie kinderendocrinologische back-up gedurende mijn werk op de 
obesitaspolikliniek. Jan Maarten en Sabine, dank voor jullie waardevolle bijdrage aan 
mijn publicaties.  
154 Dankwoord
Polikliniek-medewerkers en medewerkers van de dagbehandeling, dank voor jullie 
hulp bij de obesitaszorg. 
Medewerkers van de radiologie, LIBC en Gortercentrum, dank voor jullie hulp bij al 
mijn vragen. In het bijzonder dank aan Wouter, voor je technische hulp. Annemarieke, 
Jurriaan en Anne, dank voor jullie hulp bij de MRI-analyses, bijdrage aan artikelen en 
gezelligheid. Ik hoop in de toekomst nog veel met jullie te mogen samenwerken. Gerda, 
voor al je logistieke hulp, maar ook voor je warme persoonlijkheid, veel dank. Annelies 
Immink, dank voor al het werk dat je als mijn voorganger verzet hebt. 
Wiepke, Marinka, Yosine en Adriaan, bedankt voor jullie inzet tijdens jullie wetensc-
hapsstage en jullie bijdrage aan mijn onderzoek.  
Dr. Ron Wolterbeek en Dr.ir. Nan van Geloven, dank voor jullie statistische ondersteun-
ing. 
Mijn kamergenoten de afgelopen jaren:  Tjitske, Liselotte, Sabine, Ilona, Emmeline, De-
peng, Dennise, Vivianne, Henriëtte, Janneke en Anika, dank voor gezelligheid, feestelijke 
momenten als het goed ging, steun als het minder ging en fijne samenwerking.
Bewoners van de kamer aan de overkant: Fabienne, Caroline, Vincent, Dagmar, Ma-
aike, Leontien en Martine, het was fijn om af en toe even bij jullie binnen te vallen en te 
sparren met mensen die de weg al iets verder hebben afgelegd, waarvoor dank.
Wendy, Inge, Yvonne, Nancy en Yvonne, dank voor al jullie logistieke hulp en gezel-
ligheid.
Kinderartsen van het WAKZ, dank voor de prettige samenwerking door de jaren heen. 
Alle arts-assistenten en ex-arts-assistenten waar ik in de loop der jaren mee heb mo-
gen samenwerken, dank voor jullie steun en samenwerking. Een bijzonder  woord van 
dank aan Sebastian, Alex, Gerben, Liora, Eva en Anne, voor vele goede gesprekken over 
werk, onderzoek en  zoveel meer. 
Familie en vrienden, dank voor jullie interesse in mijn onderzoek en gezellige afleiding. 
Dirkjan en Thijs, dank voor jullie interesse in mijn traject en steun daarin en dank voor 
meer dan 20 jaar vriendschap. Ik vind het fantastisch dat jullie vandaag mijn paranimfen 
willen zijn. 
Annieke, Colinde, Leona, Erwin, Peter en Mathijs, dank voor jullie interesse in mijn 
onderzoek door de jaren heen en gezelligheid in huize de Groot. 
Lieve pa en ma, bedankt voor jullie vertrouwen, vele oppasuurtjes en het ‘thuis’ dat 
jullie nog steeds bieden. 
Lieve Marit, dank voor je steun, respect en ruimte om dit traject succesvol af te maken. 
Ik had het niet zonder je gekund. 
Lieve Sara en Noor, jullie maken het leven mooier. 
Curricculum Vitae 155
CurrICuLuM VItaE
Cornelis Jan de Groot was born on April 19th 1984 in Gorinchem. After he completed sec-
ondary school at the Oude Hoven Lyceum in Gorinchem he started his medical training 
in 2002 at the Vrije Universiteit Amsterdam. During the last period of his internships he 
focussed on paediatrics and obtained his medical degree in 2009. After graduation, he 
started working as a paediatric resident at the Tergooi Hospital in Blaricum in 2009 and 
subsequently at the Leiden University Medical Center in 2011. In May 2012 he started 
as a PhD candidate at the Willem-Alexander Children’s Hospital of the Leiden University 
Medical Center under the supervision of prof. dr. Henriette Delemarre-van de Waal, prof.
dr. Frans Walther and dr. Jeroen van der Grond. After the demise of prof dr. Henriette 
Delemarre-van de Waal at February 13th 2014 and the emigration of prof. dr. Frans Wal-
ther, prof. dr. Edmond Rings and dr. Erica van den Akker were added to his supervision 
team. This thesis describes the research performed during his period as a PhD candidate. 
In May 2016 Cornelis Jan started his clinical training in paediatrics at the Willem-
Alexander Children’s Hospital under supervision of dr. W.J.W. Kollen till November 2017 
and under the supervision of dr. R.G.M. Bredius from November 2017 onward.  Currently 
he is continuing his training at the Groene Hart Hospital in Gouda under the supervision 
of dr. Kramer-van Driel.
Cornelis Jan married Marit van Meegen on May 31st 2013. They have two daughters: 
Sara, born July 14th 2014 and Noor, born November 11th 2017.  
O
b
esity: Exp
loring
 neural p
athop
hysiolog
ical p
athw
ays and
 im
p
roving
 d
iag
nostic strateg
ies 
 
C
o
rnelis Jan d
e G
ro
o
t
